<SEC-DOCUMENT>0001140361-25-044206.txt : 20251203
<SEC-HEADER>0001140361-25-044206.hdr.sgml : 20251203
<ACCEPTANCE-DATETIME>20251203164330
ACCESSION NUMBER:		0001140361-25-044206
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251203
DATE AS OF CHANGE:		20251203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BED BATH & BEYOND, INC.
		CENTRAL INDEX KEY:			0001130713
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				870634302
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-290763
		FILM NUMBER:		251547046

	BUSINESS ADDRESS:	
		STREET 1:		433 W. ASCENSION WAY, 3RD FLOOR
		CITY:			MURRAY
		STATE:			UT
		ZIP:			84123
		BUSINESS PHONE:		8019473100

	MAIL ADDRESS:	
		STREET 1:		433 W. ASCENSION WAY, 3RD FLOOR
		CITY:			MURRAY
		STATE:			UT
		ZIP:			84123

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BEYOND, INC.
		DATE OF NAME CHANGE:	20231103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OVERSTOCK.COM, INC
		DATE OF NAME CHANGE:	20060203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OVERSTOCK COM INC
		DATE OF NAME CHANGE:	20001227
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ny20056677x2_424b2.htm
<DESCRIPTION>424B2
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Soultions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20056677x2_424b2_101-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: right;">Filed Pursuant to Rule 424(b)(2)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: right;">Registration No. 333-290763</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">PROSPECTUS</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-align: center;"><img style="height: 93px; width: 255px;" src="logo_bedbathbeyond.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">Bed Bath &amp; Beyond, Inc. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 0pt; text-align: center;">Up to 6,884,548 Shares of Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus relates to the issuance and sale of up to 6,884,548 shares of Common Stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), by Bed Bath &amp; Beyond, Inc., a Delaware corporation (&#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and like expressions), upon the exercise of warrants issued by the Company on October&#160;7, 2025, as a distribution to all holders of the shares of Common Stock on the Record Date (as defined below) (each, a &#8220;Warrant&#8221; and, collectively, the &#8220;Warrants&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Common Stock is listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;BBBY.&#8221; On October&#160;6, 2025, the last reported sale price of our Common Stock on the NYSE was $12.11 per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company declared a distribution (the &#8220;Warrant Distribution&#8221;) of transferable Warrants at no charge to all of the record holders of Common Stock as of the close of business on October&#160;2, 2025 (the &#8220;Record Date&#8221;). The Company is distributing one (1) Warrant for every ten (10) issued and outstanding shares of Common Stock, rounded down to the nearest whole number. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless the expiration date of the Warrants is accelerated pursuant to the terms of the Warrant Agreement (defined below) as a result of the Early Expiration Price Condition (defined below), the Warrants may be exercised only during the period commencing on the date of the effectiveness of the registration statement of which this prospectus is a part until October&#160;7, 2026, subject to the conditions set forth in the Warrant Agreement (as defined below). Each Warrant entitles the holder thereof to purchase from us one (1) share of Common Stock at an initial Exercise Price of $15.50 per Warrant, in each case, subject to certain adjustments. The Warrants may be exercised for cash only. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on the number of shares of Common Stock issued and outstanding as of the Record Date, if all Warrants issued in the Warrant Distribution were exercised, we would have 75,730,029 shares of Common Stock issued and outstanding following the completion of the exercise period for the Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrants have been issued by the Company pursuant to a warrant agreement, dated October&#160;7, 2025, between the Company and Computershare Trust Company, N.A., as Warrant Agent (the &#8220;Warrant Agreement&#8221;). The Warrants will be transferable when issued and are expected to trade on NYSE under the ticker BBBY WS. However, there can be no assurance that an orderly, liquid trading market for the Warrants will develop. Any trading value of the Warrants will be determined by the market. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company will receive proceeds from the exercise of the Warrants for cash. See &#8220;Use of Proceeds&#8221; in this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investing in the securities offered by this prospectus involves substantial risks. You should carefully consider the risks described under the &#8220;Risk Factors&#8221; section of this prospectus beginning on page <a href="#tRF">8</a> and similar sections in our filings with the Securities and Exchange Commission (&#8220;SEC&#8221;) incorporated by reference herein before buying any of the shares of Common Stock offered hereby.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither the SEC nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 50.5pt; text-align: center;">The date of this prospectus is December 3, 2025.</div></div></div></div>
<!--End Page 1-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_102-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.44pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 432pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 432pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP">About This Prospectus<font style="padding-left: 1.93pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tATP"><font style="padding-left: 4.44pt;">ii</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTM">Trademarks<font style="padding-left: 2.09pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tTM"><font style="padding-left: 1.66pt;">iii</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSCN">Special Cautionary Note&#160;Regarding Forward-Looking Statements<font style="padding-left: 2.92pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tSCN"><font style="padding-left: 2.22pt;">iv</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPS">Prospectus Summary<font style="padding-left: 3.97pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tPS"><font style="padding-left: 5pt;">1</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTO">The Offering<font style="padding-left: 1.37pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tTO"><font style="padding-left: 5pt;">2</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">Risk Factors<font style="padding-left: 3.41pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">8</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP">Use of Proceeds<font style="padding-left: 2.87pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tUOP">12</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">Plan of Distribution<font style="padding-left: 3.41pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tPOD">13</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">Description of the Warrants<font style="padding-left: 1.64pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOW">14</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">Description Of Capital Stock<font style="padding-left: 0.65pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDOC">22</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tMUF">Material U.S. Federal Income Tax Consequences <font style="padding-left: 1.03pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tMUF">25</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">Legal Matters<font style="padding-left: 2.86pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tLM">28</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEX">Experts<font style="padding-left: 3.95pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tEX">28</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">Where You Can Find More Information<font style="padding-left: 1.49pt;"></font></a></div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tWYC">29</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tIIR">Information Incorporated by Reference<font style="padding-left: 0.13pt;"></font></a></div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.44pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tIIR">30</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 2-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_103-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tATP"><!--Anchor--></a>ABOUT THIS PROSPECTUS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus is part of a registration statement that we filed with the SEC. This prospectus describes the specific terms of the Warrants and our shares of common stock issuable upon exercise of the Warrants. This prospectus may be supplemented from time to time to add, update or change information contained in this prospectus. Any statement that we make in this prospectus will be modified or superseded by any inconsistent statement made by us in a prospectus supplement. Any statement that we make in this prospectus will be modified or superseded by any inconsistent statement made by us in a prospectus supplement. You should read this prospectus and any prospectus supplement together with additional information described under the headings &#8220;Where You Can Find More Information&#8221; and &#8220;Information Incorporated by Reference.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We urge you to carefully read this prospectus, and the documents incorporated by reference herein and therein, before acquiring our common stock. You should rely only on the information contained in this prospectus, or incorporated by reference herein or contained in a freewriting prospectus we have prepared. We have not authorized anyone to provide you with different information. No dealer, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus. You should not rely on any unauthorized information or representation. This prospectus is an offer to sell only the securities offered hereby, and only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information in this prospectus is accurate only as of the date on the front of the applicable document and that any information we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the date of delivery of this prospectus, or any sale of a security. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither we, nor any of our representatives are making any representation to you regarding the legality of an investment in our securities by you under applicable laws. You should consult with your own advisors as to legal, tax, business, financial and related aspects of an investment in our securities. References in this prospectus to the &#8220;Company,&#8221; &#8220;Bed Bath &amp; Beyond,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us,&#8221; refer to Bed Bath &amp; Beyond, Inc. unless otherwise stated or the context otherwise requires. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">ii<br></div></div></div>
<!--End Page 3-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_103-about_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTM"><!--Anchor--></a>TRADEMARKS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus includes, or incorporates by reference, our trademarks, service marks, brand names and trade names, including, without limitation, Bed Bath &amp; Beyond, Overstock.com, and buybuy BABY, which are our property and are protected under applicable intellectual property laws. This prospectus also contains, or incorporates by reference, trademarks, service marks, brand names and trade names of other companies, which are the property of their respective owners. Any use or display of other parties&#8217; trademarks, service marks, brand names or trade names in this prospectus, or any documents incorporated by reference herein or therein does not imply, and such use or display should not be construed to imply, any affiliation with, or endorsement of or by, such third parties. Solely for convenience, trademarks, service marks, brand names, and trade names referred to in this prospectus, or any documents incorporated by reference herein or therein may appear with or without the &#174;, <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> or <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> symbols, but use (or omission) of such symbols is not intended to limit in any way our rights, or the rights of the applicable owner or any applicable licensor, in and to these trademarks, service marks, brand names, and trade names.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">iii<br></div></div></div>
<!--End Page 4-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_104-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSCN"><!--Anchor--></a>SPECIAL CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus and the documents incorporated by reference in this prospectus, and our other public documents and statements our officers and representatives may make from time to time, contain forward-looking statements within the meaning of the federal securities laws. These statements are intended to be covered by the safe harbor provisions of these laws. You can find many of these statements by looking for words such as &#8220;may,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;contemplate,&#8221; &#8220;seek,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;estimate,&#8221; or other similar terms or expressions or the negative of these terms or expressions, although not all forward-looking statements contain these identifying terms or expressions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These forward-looking statements involve known and unknown risks and uncertainties and relate to future events or our future financial or operating performance. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry and business, and on management&#8217;s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, you are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to assumptions, risks, uncertainties, and other important factors that are difficult to predict, and that actual results and outcomes may be materially different from the results, performance, achievements, or outcomes expressed or implied by any of our forward-looking statements for a variety of reasons, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we depend on third-party companies to perform functions critical to our business, and any failure or increased cost on their part could have a material adverse effect on our business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we face intense competition and may not be able to compete successfully against existing or future competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we may not timely identify or effectively respond to consumer needs, expectations or trends, which could adversely affect our relationship with our customers, the demand for our products and services, and our market share; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our business depends on effective marketing, including marketing via email, search engine marketing, influencer marketing, and social media marketing. Our competitors have and may continue to cause us to increase our marketing costs and decrease certain other types of marketing, and have and may continue to outspend us on marketing or be more efficient in their spend; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">economic factors, including recessions, other economic downturns, inflation, our exposure to the U.S.&#160;housing market, and decreases in consumer spending, have affected and could continue to adversely affect us; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">trade policies or restrictions, import and export policies, tariffs, bans, or other measures or events and related macroeconomic effects could have a material adverse effect on our business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our changing business model and use of the Overstock brand, Bed Bath &amp; Beyond brand, buybuy BABY brand, and other brands of ours, could negatively impact our business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the changing job market, the changes in our leadership team, the change in our compensation approach, changing job structures, or any inability to attract, retain and engage key personnel could affect our ability to successfully grow our business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we rely upon paid and natural search engines to rank our product offerings, and our financial results may suffer if we are unable to maintain our prior rankings in natural searches; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if we are not profitable and/or are unable to generate sufficient positive cash flow from operations, our ability to continue in business will depend on our ability to raise additional capital, obtain financing or monetize significant assets, and we may be unable to do so; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our business depends on the Internet, our infrastructure and transaction-processing systems, and catastrophic events could adversely affect our operating results; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">iv<br></div></div></div>
<!--End Page 5-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_104-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compliance with ever-evolving federal, state, and foreign laws and other requirements relating to the handling of information about individuals necessitates significant expenditure and resources, and any failure by us, our vendors or our business partners to comply may result in significant liability, negative publicity, and/or an erosion of trust, which could materially adversely affect our business, results of operations, and financial condition; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if we or our third-party providers experience cyberattacks or data security incidents, there may be damage to our brand and reputation, material financial penalties, and legal liability, which would materially adversely affect our business, results of operations, and financial condition; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">failure to comply with, or changes in, laws, regulations and enforcement activities may adversely affect the products, services and markets in which we operate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">from time to time we are subject to various legal proceedings which could adversely affect our business, financial condition or results of operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">damage to our reputation or brand image could adversely affect our sales and results of operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if we do not successfully optimize and operate shipping operations or customer service operations, our business could be harmed; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if we fail to effectively utilize technological advancements, including in artificial intelligence, our business and financial performance could be negatively impacted; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">global conflict could negatively impact our business, results of operations, and financial condition; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">product safety and quality concerns could have a material adverse impact on our revenue and profitability; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we depend on our suppliers&#8217; and fulfillment partners&#8217; representations regarding product safety, content and quality, product compliance with various laws and regulations, including registration and/or reporting obligations, and for proper labeling of products; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we have an evolving business model, which increases the complexity of our business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">investment in new business strategies, acquisitions, dispositions, partnerships, or other transactions could disrupt our ongoing business, present risks not originally contemplated and materially adversely affect our business, reputation, results of operations and financial condition; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the other risks described in this prospectus and the documents incorporated by reference herein. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In evaluating all forward-looking statements, you should specifically consider the risks outlined above and in this prospectus and the documents incorporated by reference herein and therein, especially under the headings &#8220;Special Cautionary Note Regarding Forward-Looking Statements,&#8221; &#8220;Risk Factors,&#8221; &#8220;Legal Proceedings,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and similar headings. Although we believe that our assumptions and expectations reflected in the forward-looking statements are reasonable as of the date hereof, we cannot guarantee or offer any assurance of future results, levels of activity, performance or achievements or events. Our forward-looking statements contained in this prospectus and the documents incorporated by reference herein and therein speak only as of the date of this prospectus and the documents incorporated by reference herein, and, except as required by law, we undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date hereof or any changes in our expectations or any change in any events, conditions or circumstances on which any of our forward-looking statements are based.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">v<br></div></div></div>
<!--End Page 6-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPS"><!--Anchor--></a>PROSPECTUS SUMMARY </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary provides an overview of our company and our business. This summary is not complete and does not contain all of the information you should consider before purchasing our securities. You should carefully read all of the information contained or incorporated by reference in this prospectus, including the &#8220;Risk Factors&#8221; and our consolidated financial statements and related notes contained herein and therein, before making an investment decision. Unless we specify otherwise, all references in this prospectus to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Bed Bath &amp; Beyond&#8221; and the &#8220;Company&#8221; refer to Bed Bath &amp; Beyond, Inc.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Our Company </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are an e-commerce expert with a singular focus: connecting consumers with products and services they love. As the owner of the iconic Bed Bath &amp; Beyond, Overstock and buybuy BABY brands, as well as several other brands, we strive to curate an exceptional online shopping experience. Our suite of premier online retail brands allow us to offer a comprehensive array of products and services, catering to customers in the United States. Our e-commerce platform, accessible through our mobile app, www.bedbathandbeyond.com, and www.overstock.com (collectively referred to as the &#8220;Website&#8221;), serves as a gateway for those seeking a diverse array of top-tier, on-trend products that enable its customers to unlock their homes&#8217; potential at competitive prices. From furniture, bedding, and bath essentials to patio and outdoor gear, area rugs, tabletop and cookware, d&#233;cor, storage and organization solutions, small appliances, and home improvement items &#8211; we offer an extensive range of furniture and home furnishings to elevate our customers&#8217; living spaces within the four corners of their home and the four corners of their property. We have included our Website addresses only as inactive textual references and do not intend them to be an active link to our Website or incorporate information from our Website into this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our company, based in Murray, Utah, was founded as a Utah limited liability company in 1997, reorganized as a C corporation in the State of Utah in 1998, and reincorporated in Delaware in 2002. We launched our initial website in March&#160;1999. In November&#160;2023, we changed our corporate name from Overstock.com, Inc. to Beyond, Inc., and transferred the principal listing of our common stock from the Nasdaq Global Market to the New York Stock Exchange. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our common stock ceased trading under the ticker symbol &#8220;OSTK&#8221; on the Nasdaq Global Market at the close of market November&#160;3, 2023 and on November&#160;6, 2023, our common stock began trading under the ticker symbol &#8220;BYON&#8221; on the New York Stock Exchange. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Effective August&#160;18, 2025, we changed our corporate name to Bed Bath &amp; Beyond, Inc. On August&#160;29, 2025, our common stock ceased trading under the ticker symbol &#8220;BYON&#8221; and began trading under ticker symbol &#8220;BBBY&#8221;. We will not distinguish between our prior and current corporate name and will refer to our current corporate name throughout this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our principal executive offices are located at 433 W. Ascension Way, 3rd Floor, Murray, Utah 84123, and our telephone number is (801) 947-3100. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 7-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTO"><!--Anchor--></a>THE OFFERING </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary highlights the information contained elsewhere in this prospectus. You should read carefully the following summary together with the more detailed description of the terms of the Warrants and Common Stock contained elsewhere in this prospectus. See &#8220;Description of the Warrants&#8221; and &#8220;Description of Capital Stock&#8221; in this prospectus.<font style="font-style: normal;"> </font></div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Issuer:<font style="font-weight: normal; padding-left: 4.07pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Bed Bath &amp; Beyond, Inc. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">The Warrant Distribution:<font style="font-weight: normal; padding-left: 1.6pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Our Board of Directors declared a distribution of transferable Warrants at no charge to all of our stockholders. We are distributing on October&#160;7, 2025 (the &#8220;Distribution Date&#8221;), one (1) Warrant for every ten&#160;(10)&#160;shares of our Common Stock (equaling approximately 0.10 of a Warrant per share of Common Stock), rounded down to the nearest whole number. Each Warrant will entitle the holder thereof (the &#8220;Holder&#8221;) to purchase, at the Holder&#8217;s sole and exclusive election, at the Exercise Price (defined below), one (1) share of Common Stock as set forth in &#8220;Warrant Shares&#8221; below and subject to certain adjustments described in the &#8220;Anti-Dilution Adjustments&#8221; below. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">We issued a total of 6,884,548 Warrants (which represent the right to purchase up to 6,884,548 shares of Common Stock, assuming that no Warrants or shares of Common Stock are rounded down). Our officers, directors, employees, affiliates and advisors and their respective affiliates who are also stockholders or other eligible recipients will receive Warrants similar to all other stockholders and other eligible recipients. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">Holders may exercise all or a portion of their Warrants or choose not to exercise any Warrants at all, or may otherwise sell or transfer their Warrants, in each case, in their sole and absolute discretion, subject to applicable law. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">No Fractional Warrants:<font style="font-weight: normal; padding-left: 3.93pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">The Warrant Agent (defined below) will not be required to effect any transaction that would result in the issuance of a fraction of a Warrant. If any fractional Warrant would otherwise be required to be issued or distributed, we will round down the total number of Warrants to be issued to the relevant Holder to the nearest whole number. As a result, stockholders who own fewer than ten (10) shares (or combined multiples thereof) will not be entitled to any Warrants as a result of holding such shares. For example, stockholders who own 2, 166 or 338 shares of Common Stock would receive zero, 16 and 33 warrants, respectively. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Record Date:<font style="font-weight: normal; padding-left: 5.76pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">5:00 p.m., New York City time, October&#160;2, 2025. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Shares of Common Stock Outstanding as of the Record Date:<font style="font-weight: normal; padding-left: 1.76pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">As of the Record Date, 68,845,481 shares of our Common Stock were issued and outstanding. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Shares of Common Stock Outstanding Assuming Complete Exercise of the Warrants:<font style="font-weight: normal; padding-left: 5.26pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We will not issue any shares of Common Stock directly in the Warrant Distribution. Based on the number of </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 8-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; position: relative; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 240pt; text-align: justify;">shares of Common Stock outstanding as of the Record Date, if all 6,884,548 Warrants issued in the Warrant Distribution were exercised, we would have 75,730,029&#160;shares of Common Stock outstanding (in each case, assuming no Warrants or shares of Common Stock are rounded down).<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Warrant Shares:<font style="font-weight: normal; padding-left: 2.92pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Each Warrant will be exercisable for one (1) share of our Common Stock, subject to certain adjustments described in &#8220;Warrant Exercise Rate Adjustments&#8221; below. Such number of shares of Common Stock, as it may be adjusted, is referred to as the &#8220;Warrant Exercise Rate.&#8221; </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">No Fractional Shares:<font style="font-weight: normal; padding-left: 4.16pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">The Company will not issue fractional shares of Common Stock, or pay cash in lieu thereof, upon the exercise of the Warrants. If a stockholder would be entitled to receive a fractional number of shares of Common Stock upon exercise of the Warrants, we will round down the total number of shares of Common Stock to be issued to such stockholder to the nearest whole number. The Company&#8217;s calculation shall be determinative. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Exercise Price:<font style="font-weight: normal; padding-left: 4.72pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">$15.50 per Warrant (the &#8220;Exercise Price&#8221;). The Exercise Price must be paid in cash. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Issuance of Common Stock Upon Exercise of Warrants:<font style="font-weight: normal; padding-left: 3.07pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">If you are a holder of record of our Common Stock and you exercise your Warrants to purchase Common Stock, our transfer agent will issue a direct registration account statement representing those shares to you as soon as practicable after the exercise of the Warrants. If your shares are held through a broker, dealer, custodian bank or other nominee and you exercise your Warrants, your account at your nominee will be credited with those shares as soon as practicable following the exercise of your Warrants. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Exercise Period:<font style="font-weight: normal; padding-left: 4.6pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Subject to applicable laws and regulations, the Warrants may be exercised only during the period commencing on the date of the effectiveness of the registration statement of which this prospectus is a part until 5:00 p.m. New&#160;York City time on the Expiration Date (defined below). </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">Any otherwise valid exercise of Warrant submitted after the applicable deadline for exercise may, in the sole and absolute discretion of the Company, be accepted and honored. The Company&#8217;s decision with respect to any such exercise shall be determinative. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Expiration Date:<font style="font-weight: normal; padding-left: 2.74pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Unless the Early Expiration Price Condition (defined below) is met, the Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on </div></div><div class="BRDSX_block-footnote" style="width: 468pt; margin-left: 0pt;"><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;"> </div></div></div><div class="BRDSX_block-footnote" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 10pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;"><font style="position: relative; top: -3.25pt;">(1)</font><br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 8pt;"><font style="font-size: 8pt;">The number of shares of our common stock that would be outstanding after this offering, assuming the exercise, issuance and sale of all shares of our Common Stock offered hereby is based on 68,845,481 shares of common stock outstanding as of the Record Date. It excludes, as of such date, (i) 2,549,143 shares of our Common Stock that may be issued upon the vesting of outstanding restricted stock units and performance stock units, (ii) 2,250,000 shares of Common Stock issuable upon the exercise of outstanding stock options, (iii) 146,642 shares of our Common Stock that remain available for future equity grants under our equity incentive plan, and (iv) 2,541,352 shares of our Common Stock that remain available for issuance under our employee stock purchase plan.</font></div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 9-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 240pt; text-align: justify;">October&#160;7, 2026 (the &#8220;Expiration Date&#8221;). As summarized in &#8220;Early Expiration Price Condition and Date&#8221; below, the Expiration Date is subject to automatic acceleration upon satisfaction of the Early Expiration Price Condition. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Early Expiration Price Condition and Date:<font style="font-weight: normal; padding-left: 4.44pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Upon the occurrence of the first 30 consecutive Trading Day (as defined in the Warrant Agreement) period (the &#8220;Reference Period&#8221;) that includes 20 Qualifying Trading Days (whether or not consecutive) the first of which 20&#160;Qualifying Trading Days must fall on or after the first&#160;Trading Day immediately following the Issue Date (the &#8220;Early Expiration Price Condition&#8221;, and the last of such 20 Qualifying Trading Days to occur, the &#8220;Early Expiration Price Condition Date&#8221;), the Expiration Date will automatically accelerate to the date (the &#8220;Early Expiration Date&#8221;) that is the business day immediately following the Early Expiration Price Condition Date. Notwithstanding the foregoing, the Company may set an Alternate Expiration Date (defined below) in accordance with the provisions described below and as further described in the Warrant Agreement. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">&#8220;Qualifying Trading Day&#8221; means any Trading Day on which the daily VWAP (as defined in the Warrant Agreement) of a share of Common Stock is at least equal to the Early Expiration Trigger Price in effect on the last day of the Reference Period. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">The &#8220;Early Expiration Trigger Price&#8221; is initially equal to $18.60, subject to certain adjustments described in &#8220;Warrant Exercise Rate Adjustments&#8221; below. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">In the event of an early expiration of the Warrants, Warrants will be exercisable until 5:00 p.m. New York City time on the Early Expiration Date, unless an Alternate Expiration Date is set as provided below. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">If the Early Expiration Price Condition occurs, the Company will make a public announcement to that effect by issuance of a press release (the &#8220;Early Expiration Price Condition Notice&#8221;) as promptly as practicable after market close on the Early Expiration Price Condition Date setting forth the Early Expiration Date or an Alternate Expiration Date as set forth below. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Alternate Expiration Date:<font style="font-weight: normal; padding-left: 0.88pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">The Company may, in its sole discretion, elect to set the Early Expiration Date on a date falling after the business day immediately following the Early Expiration Price Condition Date (such date, an &#8220;Alternate Expiration Date&#8221;). Any such Alternate Expiration Date shall be specified in the Early Expiration Price Condition Notice. In order to exercise the right to set an Alternate Expiration Date, the Company shall, no later than the fifth Qualifying Trading Day (whether or not consecutive) occurring in any 20 consecutive Trading Day period, make a public announcement by issuance of </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 10-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 240pt; text-align: justify;">a press release that the Company is reserving the right to set an Alternate Expiration Date in the event the Early Expiration Price Condition does occur.</div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">If the Company sets an Alternate Expiration Date, the expiration of the Warrants on such Alternate Expiration Date shall be conditioned on the daily VWAP of a share of Common Stock being at least equal to the quotient of the Exercise Price divided by the Warrant Exercise Rate for each of the two Trading Days immediately preceding such Alternate Expiration Date (the &#8220;Additional Price Condition&#8221;). As promptly as practicable after market close on the Trading Day immediately preceding the Alternate Expiration Date, the Company will make a public announcement by issuance of a press release as to whether the Additional Price Condition is met. The Company may, in its sole discretion, in any such press release, postpone (on one or more occasions) such Alternate Expiration Date to a new Alternate Expiration Date. </div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 240pt; text-align: justify;">If the Additional Price Condition is not met as to an Alternate Expiration Date specified by the Company, unless the Company sets a new Alternate Expiration Date as set forth in the preceding paragraph (an &#8220;Alternate Expiration Date Annulment&#8221;), the Expiration Date will remain October&#160;7, 2026 unless another Early Expiration Price Condition Date subsequently occurs. The definition of Early Expiration Price Condition, Early Expiration Price Condition Date and Reference Period are subject to appropriate adjustment as set forth in the Warrant Agreement in the event of an Alternate Expiration Date Annulment. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Form, Transfer and Exchange:<font style="font-weight: normal; padding-left: 1.36pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Indirect &#8220;street name&#8221; holders of Warrants should contact their broker, bank or other intermediary for information on how to transfer or exercise Warrants. The deadlines of such intermediaries or of the DTC may be earlier than the stated deadlines set forth in the Warrant Agreement and described in this prospectus. Record holders of Warrants should contact the Warrant Agent for information on how to transfer or exercise Warrants. The deadlines established by the Warrant Agent may also be earlier than the stated deadlines set forth in the Warrant Agreement and described in this prospectus. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Warrant Exercise Rate Adjustments:<font style="font-weight: normal; padding-left: 5.19pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">The Warrant Exercise Rate is subject to certain adjustments for events including: (i) stock dividends, splits, subdivisions, reclassifications and combinations; (ii) other distributions and spinoffs; and (iii) shareholder rights plans, and may be amended by the Company. The Early Expiration Trigger Price is subject to proportional adjustment when the Warrant Exercise Rate is adjusted or amended or the Exercise Price is amended. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Use of Proceeds:<font style="font-weight: normal; padding-left: 3.5pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Assuming that all Warrants distributed are fully exercised for cash, we would receive proceeds of approximately $106.7&#160;million in the aggregate, after </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 11-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 240pt; text-align: justify;">deducting estimated commissions and estimated offering expenses. We intend to use the proceeds of any Warrant exercises for general corporate purposes. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Absence of a Public Market:<font style="font-weight: normal; padding-left: 4.55pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">The Warrants are new securities and there is no established trading market for the Warrants. Accordingly, there can be no assurances as to the development or liquidity of any market for the Warrants. The Warrants will be listed for trading on the NYSE under the ticker BBBY WS. There can be no assurance that any such market will be available for trading of the Warrants. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Listing of Shares of Common Stock:<font style="font-weight: normal; padding-left: 0.85pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Shares of our Common Stock trade on the NYSE under the symbol BBBY. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Maintenance of Registration Statement:<font style="font-weight: normal; padding-left: 4.24pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We will use our commercially reasonable efforts to keep a registration statement effective, subject to certain exceptions, covering the issuance of the Common Stock issuable upon the exercise of the Warrants. If the registration statement ceases to be effective for any reason at the time of exercise of any Warrants, the right to exercise Warrants shall be automatically suspended until such registration statement becomes effective (any such period, an &#8220;Exercise Suspension Period&#8221;). The Company shall provide notice by press release, with a copy to the Warrant Agent, of any Exercise Suspension Period. No Early Expiration Price Condition Date, and no calculation of the VWAP for purposes of determining the Early Expiration Price Condition Date, shall occur during any Exercise Suspension Period. If the Expiration Date would otherwise fall in an Exercise Suspension Period, notwithstanding anything to the contrary in the Warrant Agreement, the Expiration Date shall be extended by the number of days included in such Exercise Suspension Period. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Rights as a Stockholder:<font style="font-weight: normal; padding-left: 4.87pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Holders of Warrants do not have any rights as a stockholder with respect to the shares of Common Stock issuable upon exercise of the Warrants prior to the time such Warrants are validly exercised, and the Exercise Price is paid. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Settlement:<font style="font-weight: normal; padding-left: 2.64pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">Shares of Common Stock issuable upon exercise of Warrants are expected to be delivered to the applicable Holder as soon as commercially practicable after the applicable Exercise Date (as defined in the Warrant Agreement). Holders may not receive the shares within the typical one or two business day settlement after exercise of their Warrants. The Company reserves the right to change the settlement mechanics, and timing of settlement, as needed. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Governing Law:<font style="font-weight: normal; padding-left: 4.4pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">The Warrants and the Warrant Agreement under which they are issued are governed by the laws of the State of New York. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Warrant Agent:<font style="font-weight: normal; padding-left: 0.63pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Computershare Trust Company N.A. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 12-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20056677x2_424b2_105-summary_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Risk Factors:<font style="font-weight: normal; padding-left: 5.19pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">You should carefully read the section entitled &#8220;Risk&#160;Factors&#8221; on page <a href="#tRF">8</a> of this prospectus. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">U.S. Federal Income Tax Consequences:<font style="font-weight: normal; padding-left: 3.11pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">You should carefully read the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; on page <a href="#tRF">8</a> of this prospectus, and consult your tax advisors on tax treatment of the Warrants. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Important Dates </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Please take note of the following important dates and times in connection with the Warrants and shares of Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 168pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Relevant Date</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Calendar Date or Method of Determination of Date </div></td></tr><tr><td style="width: 168pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Record Date for holders of Common Stock to Receive Warrant Distribution:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">October&#160;2, 2025 </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Issuance Date of Warrant Distribution:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">October&#160;7, 2025 </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expiration Date:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">October&#160;7, 2026, unless the Early Expiration Price Condition is met. </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">If the Early Expiration Price Condition is met, then the Expiration Date will be the Business Day immediately following the Early Expiration Price Condition Date, unless the Company sets an Alternate Expiration Date. </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Early Expiration Price Condition Date:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The last day of the first 30 consecutive Trading Day period that includes 20 Qualifying Trading Days (whether or not consecutive) the first of which 20 Qualifying Trading Days must fall on or after the first Trading Day immediately following the Issue Date. </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deadline for Exercise if the Warrants Expire:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">5:00 p.m. New York City time on the Expiration Date, as adjusted pursuant to the Early Expiration Price Condition. </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dates Warrants can be Exercised:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">During the period commencing on the date of the effectiveness of the registration statement of which this prospectus is a part until 5:00 p.m. New York City time on the Expiration Date, as adjusted pursuant to the Early Expiration Price Condition. </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Date of Payment of Exercise Price for Valid Exercise of Warrants:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Exercise Price for the Warrants must be paid prior to 5:00 p.m. New&#160;York City time on the applicable Exercise Date. </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Settlement Date for exercises of Warrants:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 288pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">As soon as commercially practicable following the applicable Exercise Date.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 13-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_106-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks and uncertainties described under the heading &#8220;Risk Factors&#8221; contained or incorporated by reference in this prospectus, including the risk factors incorporated by reference herein from our most recent Annual Report on Form&#160;10-K and subsequently filed Quarterly Reports on Form&#160;10-Q, as well as any amendments or updates thereto reflected in subsequent filings we make with the SEC. The risks described in these documents are not the only ones we face. There may be other unknown or unpredictable economic, business, competitive, regulatory, or other factors that could harm our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations, or cash flow could be harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment. Please also read carefully the section below titled &#8220;Special Cautionary Note&#160;Regarding Forward-Looking Statements.&#8221;<font style="font-style: normal;"> </font></div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">The price of the Warrants may decline rapidly and significantly following their distribution. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If there is little or no market demand for the Warrants once trading begins, the trading price of the Warrants will likely decline following their distribution. Warrants are being distributed all at once, which could lead to demand and supply imbalances and cause the trading price of the Warrants to decline rapidly and significantly. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">An active public market for the Warrants may not develop, which would adversely affect the liquidity and market price of the Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to this Warrant Distribution, there has been no existing trading market for the Warrants. After we issue the Warrants and they start to trade on NYSE, they will be subject to trading dynamics over which we will have no control. An active and orderly trading market for the Warrants may never develop or, if it develops, it may not be sustained. The trading market for the Warrants may lack adequate size, liquidity or price transparency or may have an unusually high bid-ask spread. You may be unable to sell your Warrants at a price that is favorable to you. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The trading price for the Warrants may bear little or no relationship to traditional valuation methods, or to the market price of our Common Stock, and therefore the trading price of the Warrants may fluctuate significantly following their issuance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The trading price of the Warrants may have little or no relationship to, and may be significantly lower, or at times higher, than the price that would otherwise be established using traditional indicators of value, such as our future prospects and those of our industry in general; future potential revenues, earnings, cash flows, and other financial and operating information, or multiples thereof; market prices of securities and other financial and operating information of companies engaged in drug development activities similar to ours; and the views of research analysts. Potential investors should not buy Warrants in the open market unless they are willing to take the risk that the trading price of the Warrants could fluctuate and decline significantly. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Hedging arrangements relating to the Warrants may affect the value and volatility of our Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to hedge their financial positions, Warrant holders may enter into hedging transactions with respect to our Common Stock, may unwind or adjust hedging transactions and may purchase or sell large blocks of our Common Stock in one or more market transactions. The effect, if any, of these activities on the trading price of our Common Stock will depend in part on market conditions and cannot be known in advance, but any of these activities could adversely affect the value and price volatility of our Common Stock. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Exercising the Warrants is a risky investment and you may not be able to recover the value of your investment in the Common Stock received upon exercise of the Warrants. You should be prepared to sustain a total loss of the exercise price of your Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of October&#160;6, 2025, the last reported price of our Common Stock on the NYSE was $12.11 per share. In order for you to recover the value of your investment in the shares of Common Stock received upon exercise of a Warrant at the exercise price, the value of such shares of Common Stock must be more than the exercise price of the Warrants. While the price per share of our Common Stock was $12.11 as of October&#160;6, 2025, if the value of the shares of Common Stock you receive upon exercise of a Warrant is lower than the amount you pay to the exercise the Warrant, you could experience a total loss of your investment in exercising the Warrants. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 14-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_106-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">You may lose some or all of your financial investment after exercising a Warrant. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You may incur a financial or other loss upon or subsequent to the exercise of a Warrant due to a drop in our stock price, or by a failure to timely deliver Warrant shares as of any particular date after exercise, or for other reasons. If the market value of our Common Stock price declines, you may be unable to resell your shares at or above the price at which you acquired them through the exercise of Warrants. We cannot assure you that the price of our Common Stock will not fluctuate or decline significantly below your exercise price in the future, in which case you could incur substantial losses. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The trading price of the shares of our Common Stock and Warrants could be highly volatile, and purchasers of our Common Stock or Warrants could incur substantial losses. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During calendar year 2025 to-date, the closing sale price of shares of our Common Stock on NYSE has been reported as low as $3.68 per share and as high as $12.11 per share. This volatility may affect the price at which you could sell the shares of our Common Stock or Warrants, and the sale of substantial amounts of our Common Stock or Warrants could adversely affect the price of our Common Stock or Warrants. The trading prices of our Common Stock and Warrants are likely to continue to be volatile and subject to significant price and volume fluctuations in response to market and other factors, including those described in the sections captioned &#8220;Risk Factors&#8221; in this prospectus and the documents incorporated by reference herein and therein. Additionally, broad market and industry factors may negatively affect the market price of our Common Stock and Warrants, regardless of our actual operating performance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As a result, you may not be able to sell your shares of Common Stock or Warrants at or above the price at which you purchase them. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Speculation in our publicly-traded Common Stock or Warrants may result in extreme price volatility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our stockholders or Warrant holders or outside investors may speculate on the direction of movements in the price of our Common Stock or Warrants. Speculation in the price of our Common Stock or Warrants may involve long and short exposures. Sudden changes in demand or supply for our Common Stock or Warrants due to speculation or other reasons may create trading anomalies that add volatility to the trading price of these securities. The volatility or direction of our stock price or Warrant price may be unrelated or disproportionate to our operating results, which could cause significant losses to your investments. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The settlement process for shares of Common Stock issuable upon exercise of Warrants is outside of our control and may cause you to lose the value of your investment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The settlement process with respect to exercised Warrants refers to the time between exercise of a Warrant and when the issued Common Stock is delivered to your account, and you become the holder of record of such Common Stock. The settlement process is conducted by outside parties and broker-dealers and is therefore outside of our control. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under Rule&#160;15c6-1 of the Securities Exchange Act of 1934, the standard settlement cycle for most broker-dealer transactions is one business day, unless the parties to any such trade expressly agree otherwise. We understand that under existing financial industry practices, delivery of the shares of Common Stock upon exercise of Warrants will likely not occur within one business day, and delivery may take several business days. You could experience a significant loss of your investment in exercising Warrants if the settlement process takes longer than anticipated or fails to settle. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">The issuance of Common Stock upon the exercise of the Warrants may depress our stock price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We could issue a maximum of up to 6,884,548 shares of Common Stock in connection with the Warrant Distribution, which would be an approximately 10.0% increase from our current number of shares outstanding. The issuance of such additional shares of Common Stock upon exercise of the Warrants, and the resale of such shares on the open market after their issuance, or the perception that such sales could occur, could result in significant downward pressure on our stock price. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Warrant holders will not be entitled to any of the rights of holders of our Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Warrant holders will not be entitled to any rights with respect to our Common Stock, including, without limitation, voting rights and rights to receive any dividends or other distributions on our Common Stock, but Warrant holders will be subject to all changes affecting our Common Stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 15-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_106-risk_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You will have rights with respect to our Common Stock only if you receive our Common Stock upon exercising the Warrants for cash and only as of the date when you become a record owner of the shares of our Common Stock upon such exercise. For example, if an amendment is proposed to our charter or bylaws requiring stockholder approval and the record date for determining the stockholders of record entitled to vote on the amendment occurs prior to the date you are deemed to be the owner of the shares of our Common Stock due upon exercise of your Warrants, you will not be entitled to vote on the amendment, although you will nevertheless be subject to any changes in the powers, preferences or special rights of our Common Stock. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Because we do not currently intend to pay cash dividends on our Common Stock, stockholders will benefit from an investment in our Common Stock primarily if it appreciates in value. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We do not currently anticipate paying any cash dividends on shares of our Common Stock. Any determination to pay dividends in the future would be made by our Board of Directors and would depend upon results of operations, financial conditions, contractual restrictions, restrictions imposed by applicable law, and other factors our Board of Directors would deem relevant. Accordingly, realization of a gain on stockholders&#8217; investments will primarily depend on the appreciation of the price of our Common Stock. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Our management will have broad discretion in the use of any net proceeds from this offering and may allocate any net proceeds from this offering in ways that you and other stockholders may not approve. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our management will have broad discretion in the application of the net proceeds, if any, from this offering, including for any of the purposes described in the section entitled &#8220;Use of Proceeds,&#8221; and could spend the net proceeds in ways with which you may not agree. Accordingly, you will be relying on the judgment of our management with regard to the use of the net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net proceeds are being used appropriately. It is possible that the net proceeds will be invested or otherwise used in a way that does not yield a favorable, or any, return for us, or that does not improve our operating results or enhance the value of our Common Stock or other securities. Because of the number and variability of factors that will determine our use of any net proceeds from the exercise of Warrants, the ultimate use of such net proceeds may vary substantially from their currently intended use. The failure of our management to use these net proceeds, if any, effectively could harm our business.</div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The Warrants do not automatically exercise, and any Warrant you do not exercise prior to the Expiration Date will lose all financial value. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Your Warrants do not automatically exercise, even if our Common Stock price remains at or above the exercise price of the Warrants. You are entitled to exercise the full number of Warrants registered in your name or any portion thereof. Any Warrant that you do not exercise for cash prior to the Expiration Date will expire unexercised and you will not receive any shares of our Common Stock. If the Early Expiration Price Condition occurs, the Expiration Date of your Warrants could be accelerated significantly. The Warrants will have no financial value after the Expiration Date. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Future sales or other dilution of our equity may adversely affect the market price of our Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrant Agreement does not restrict us from issuing additional shares of Common Stock to the public or under our employee and director compensation plans. We regularly evaluate opportunities to access capital markets, taking into account our capital needs, financial condition, strategic plans and other relevant considerations. The issuance of additional shares of Common Stock or common equivalent securities in future equity offerings will dilute the ownership interest of our existing Common Stockholders and may depress the trading value of the Warrants or our Common Stock. There can be no assurances that we will not in the future determine that it is advisable or necessary to issue additional shares of Common Stock or other securities convertible or exercisable for shares of Common Stock to fund our business needs. We also expect to continue to use equity and stock options to compensate our employees and directors and others. The market price of our Common Stock and the Warrants could decline significantly as a result of such offerings or issuances, or the perception that such offerings or issuances could occur. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Our registration statement covering the issuance of Common Stock issuable upon exercise of the Warrants may not be available at times. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will use our commercially reasonable efforts to keep a registration statement effective, subject to certain exceptions, covering the issuance of the Common Stock issuable upon the exercise of the Warrants; however, we are not prohibited from suspending the use of the registration statement and can suspend it at any time at our discretion </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 16-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_106-risk_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">as described in this prospectus under the heading &#8220;Description of the Warrants &#8211; Registration and Suspension.&#8221; If at the time of exercise of Warrants, there is no effective registration statement covering the issuance of the shares of Common Stock underlying the Warrants, the right to exercise Warrants shall be automatically suspended until such registration statement becomes effective (any such period, an &#8220;Exercise Suspension Period&#8221;). The Company shall provide notice by press release, with a copy to the Warrant Agent, of any Exercise Suspension Period. If the Expiration Date would otherwise fall in an Exercise Suspension Period, notwithstanding anything to the contrary in the Warrant Agreement, the Expiration Date shall be extended by the number of days included in such Exercise Suspension Period. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">We will require additional capital to support business growth, and this capital might not be available on favorable terms, or at all. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our operations or expansion efforts will require substantial additional financial, operational, and managerial resources and we will need to raise additional funds to expand our operations. We may seek debt financing or additional equity capital. Additional capital may not be available to us, or may only be available on terms that adversely affect our existing stockholders, or that restrict our operations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For example, if we raise additional funds through issuances of equity or convertible debt securities, our existing stockholders could suffer dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our Common Stock. Upon liquidation, holders of our debt securities and lenders with respect to other borrowings will receive distributions of our available assets prior to the holders of our Common Stock. Since our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. Thus, our stockholders bear the risk of our future offerings reducing the market price of our Common Stock.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 17-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_107-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUOP"><!--Anchor--></a>USE OF PROCEEDS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The net proceeds of this offering, if any, will be used for general corporate purposes. Assuming that all of the Warrants are fully exercised for cash, we expect that the net proceeds of this offering would be approximately $106.7&#160;million, after deducting estimated commissions and estimated offering expenses. We cannot assure you that any of the Warrants will be exercised or that, if any Warrants are exercised, we will use the resulting proceeds in a way with which you agree. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 18-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_108-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPOD"><!--Anchor--></a>PLAN OF DISTRIBUTION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Promptly following the effective date of the registration statement of which this prospectus is a part, we will distribute shares of our common stock to any holder upon the valid exercise of the Warrants in accordance with the terms of the Warrant Agreement. If a holder wishes to exercise the Warrants and purchase shares of our common stock, such holder should deliver a completed form of election to purchase shares of Common Stock, which contains certain representations by the holder of the Warrants, and payment of the Exercise Price in cash. See &#8220;Description of Warrants&#8221; and the Warrant Agreement, which is filed as an exhibit to the registration statement of which this prospectus forms a part, for more information concerning the exercise of the Warrants.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 19-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOW"><!--Anchor--></a>DESCRIPTION OF THE WARRANTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On October&#160;7, 2025, the Company is issuing up to 6,884,548 Warrants as a distribution to holders of record of shares of Common Stock on October&#160;2, 2025 (the &#8220;Record Date&#8221;). The Warrants are being issued by the Company pursuant to the Warrant Agreement. The following description of the Warrants and the Warrant Agreement is only a brief summary and is qualified in its entirety by reference to the complete description of the terms of the Warrants set forth in the Warrant Agreement (including the Form&#160;of Warrant attached thereto), which has been filed as an exhibit to our Current Report on Form&#160;8-K, filed on the date of this prospectus. The issuance of the Warrants has not been registered under the Securities Act because the issuance of a dividend in the form of a Warrant for no consideration is not a sale or disposition of a security or interest in a security for value pursuant to Section&#160;2(a)(3) of the Securities Act. We have applied to list the Warrants on NYSE. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Warrant Exercise Rate </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each Warrant represents the right to purchase from the Company one share of Common Stock (the &#8220;Warrant Exercise Rate&#8221;) for cash at an initial exercise price of $15.50 (the &#8220;Exercise Price&#8221;) per Warrant, payable in U.S.&#160;dollars. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrant Exercise Rate is subject to certain adjustments described in the &#8220;Anti-Dilution Adjustments&#8221; section below. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Expiration </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless the Early Expiration Price Condition is met as described below, the Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on October&#160;7, 2026 (the &#8220;Expiration Date&#8221;). The Expiration Date is subject to automatic acceleration upon satisfaction of the Early Expiration Price Condition. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon the occurrence of the first 30 consecutive Trading Day period that includes 20 Qualifying Trading Days (whether or not consecutive) the first of which 20 Qualifying Trading Days must fall on or after the first Trading Day immediately following the Issue Date (the &#8220;Early Expiration Price Condition&#8221; and the last of such 20 Qualifying Trading Days to occur, the &#8220;Early Expiration Price Condition Date&#8221;), the Expiration Date will automatically accelerate to the date (the &#8220;Early Expiration Date&#8221;) that is the business day immediately following the Early Expiration Price Condition Date, unless an Alternate Expiration Date is set as provided below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Early Expiration Price Condition occurs, the Company will make a public announcement to that effect by issuance of a press release (the &#8220;Early Expiration Price Condition Notice&#8221;) as promptly as practicable after market close on the Early Expiration Price Condition Date setting forth the Early Expiration Date or an Alternate Expiration Date as set forth below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company may, in its sole discretion, elect to set the Early Expiration Date on a date falling after the business day immediately following the Early Expiration Price Condition Date (such date, an &#8220;Alternate Expiration Date&#8221;). In order to exercise the right to set an Alternate Expiration Date, the Company shall, no later than the fifth Qualifying Trading Day (whether or not consecutive) occurring in any 20 consecutive Trading Day period, make a public announcement by issuance of a press release that the Company is reserving the right to set an Alternate Expiration Date in the event the Early Expiration Price Condition does occur. If the Company sets an Alternate Expiration Date, the expiration of the Warrants on such Alternate Expiration Date shall be conditioned on the daily VWAP of a share of Common Stock being at least equal to the quotient of the Exercise Price divided by the Warrant Exercise Rate for each of the two Trading Days immediately preceding such Alternate Expiration Date (the &#8220;Additional Price Condition&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As promptly as practicable after market close on the Trading Day immediately preceding the Alternate Expiration Date, the Company will make a public announcement by issuance of a press release as to whether the Additional Price Condition is met. The Company may, in its sole discretion, in any such press release, postpone (on&#160;one or more occasions) such Alternate Expiration Date to a new Alternate Expiration Date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Additional Price Condition is not met as to an Alternate Expiration Date specified by the Company, unless the Company sets a new Alternate Expiration Date as set forth in the preceding paragraph (an &#8220;Alternate Expiration Date Annulment&#8221;), the Expiration Date will remain October&#160;7, 2026 unless another Early Expiration Price Condition Date subsequently occurs. The definition of Early Expiration Price Condition, Early Expiration Price Condition Date and Reference Period are subject to appropriate adjustment as set forth in the Warrant Agreement in the event of an Alternate Expiration Date Annulment. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 20-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the purposes of the foregoing, &#8220;VWAP&#8221; of the Common Stock (or other security) on any date of determination means, (i) in the case of the Common Stock, for any day on which trading in the Common Stock generally occurs on the Exchange (or, if the Common Stock is not listed on the Exchange, the U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of the Common Stock on such day), the per-share volume-weighted average price based on all trades in the consolidated tape system as displayed on Bloomberg page &#8220;BBBY US Equity HP&#8221; (setting: &#8220;Volume Weighted Average Line&#8221;) (or its equivalent successor if such page or setting is not available) in respect of such day and (ii) in the case of any other security, for any day on which trading in such security generally occurs on the Exchange (or, if such security is not listed on the Exchange, the U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading of such security on such day), the per-share volume-weighted average price based on all trades in the consolidated tape system as displayed on Bloomberg page &#8220;HP&#8221; for such security in respect of such day. If such information is not so available for the Common Stock or such other security, the VWAP on such date shall be the Last Reported Sale Price for the Common Stock or such other security on such day. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A &#8220;Trading Day&#8221; for the purposes of the foregoing definition means a day on which the Common Stock (or&#160;other security) (i) at the close of regular way trading (not including after-hours or extended market trading) is not suspended from trading on the Exchange or, if the Common Stock (or such other security, as the case may be) is not listed on the Exchange, any U.S. national or regional securities exchange or association or over-the-counter market that is the primary market for the trading the Common Stock (or such other security, as the case may be) at the Close of Business, and (ii) has traded at least once regular way on the Exchange or, if the Common Stock (or such other security, as the case may be) is not listed on the Exchange, such other U.S. national securities exchange or association or over-the-counter market that is the primary market for the trading of the Common Stock (or such other security, as the case may be); provided that if the Common Stock (or such other security, as the case may be) is not so listed or traded, &#8220;Trading Day&#8221; means a Business Day. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A &#8220;Qualifying Trading Day&#8221; for purposes of the foregoing means any Trading Day on which the VWAP of the Common Stock on such Trading Day is at least equal to the Early Expiration Trigger Price in effect on the last day of the Reference Period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The &#8220;Early Expiration Trigger Price&#8221; is initially equal to $18.60, subject to certain adjustments. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to applicable laws and regulations and the terms of the Warrant Agreement, including the occurrence of the Early Expiration Price Condition or the Additional Price Condition, the Warrants may be exercised only during the period commencing on the date of the effectiveness of the registration statement of which this prospectus is a part until 5:00 p.m. New York City time on the Expiration Date. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Form&#160;and Transfer </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is issuing the Warrants in uncertificated, direct registration form. Warrant holders will not be entitled to receive physical certificates. Registration of ownership will be maintained by the Warrant Agent. If you are a holder of record of shares of Common Stock as of the Record Date, the Warrant Agent will issue a direct registration account statement representing those Warrants. For holders of shares of Common Stock as of the Record Date that hold such shares through a broker, dealer, custodian bank or other nominee, the Warrants will be represented by a global security registered in the name of a depository, which will be the holder of all the Warrants represented by the global security. Those holders who own beneficial interests in a global Warrant will do so through participants in the depository&#8217;s system, and the rights of these indirect owners will be governed solely by the applicable procedures of the depository and its participants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrant Agent will not be required to effect any registration of transfer or exchange that would result in any fraction of a Warrant. If any fractional Warrant would otherwise be required to be issued or distributed, the Company or the Warrant Agent, as applicable, will round down the total number of Warrants to be issued to the relevant holder to the nearest whole number. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Record owners of Warrants may transfer Warrants through the process established by the Warrant Agent. Indirect, &#8220;street name&#8221; holders of Warrants should contact their broker, bank or other intermediary for information on how to transfer Warrants. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 21-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Exercise </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All or any part of the Warrants may be exercised during the period commencing on the date of the effectiveness of the registration statement of which this prospectus is a part until 5:00 p.m. New York City time on the Expiration Date (as it may be adjusted) by delivering a completed form of election to purchase shares of Common Stock, which contains certain representations by the holder of the Warrants, and payment of the Exercise Price in cash. Any such delivery that occurs on a day that is not a Business Day or is received after 5:00 p.m., New York City time, on any given Business Day will be deemed received and exercised on the next succeeding Business Day. Record owners of Warrants may exercise Warrants through the process established by the Warrant Agent. Indirect, &#8220;street name&#8221; holders of Warrants should contact their broker, bank or other intermediary for information on how to exercise Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a registration statement is not effective at any time or from time to time, the right to exercise Warrants shall be automatically suspended until such registration statement becomes effective as described under &#8220;Registration and Suspension&#8221; below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon delivery of Warrant Shares upon exercise of Warrants, the Company will issue such whole number of Warrant Shares as the exercising Warrant holder is entitled to receive. If your Warrants are held through a broker, dealer, custodian bank or other nominee and you exercise your Warrants, your account at your nominee will be credited with those shares following the exercise of your Warrants. If you are a holder of record of our Common Stock and you exercise your Warrants, our transfer agent will issue a direct registration account statement representing those shares to you after the exercise of the Warrants. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Amendment </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrant Agreement may be amended without the consent of any Warrant holder to cure any ambiguity, omission, defect or inconsistency, to provide for the assumption by a successor company in any Business Combination (as defined in the Warrant Agreement), to extend the Expiration Date, to decrease the Exercise Price or increase the Warrant Exercise Rate, to provide for net share settlement upon exercise of the Warrants, to make any change that does not adversely affect the rights of any holder in any material respect, to provide for a successor Warrant Agent or Calculation Agent, in connection with any business combination, to provide that the Warrants are exercisable for units of reference property or to conform the provisions of the Warrant Agreement or the certificates for the Warrant this &#8220;Description of the Warrants&#8221; section of this prospectus. The consent of a majority in interest of the then-outstanding Warrants is required for any amendment that materially and adversely affects the interests of the holders of the then-outstanding Warrants. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Registration and Suspension </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has agreed in the Warrant Agreement to use commercially reasonable efforts to cause a shelf registration statement (including, at the Company&#8217;s election, an existing registration statement), filed pursuant to Rule&#160;415 (or any successor provision) of the Securities Act, covering the issuance of shares of Common Stock to the Warrant holders upon exercise of the Warrants to remain effective until the earlier of (i) such time as all Warrants have been exercised and (ii) the Expiration Date. The Company may suspend the availability of the registration statement relating to the Warrants from time to time if the Board of Directors of the Company determines that such a suspension would be necessary or desirable, as determined by the Company in its sole discretion, and the Company provides notice to the Warrant holders. No calculation of the VWAP for purposes of determining the Early Expiration Price Condition shall occur during any period in which the registration statement is suspended, and if the Expiration Date would otherwise fall in an period in which the registration statement is suspended, the Expiration Date shall be delayed by the number of days comprised in such Exercise Suspension Period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will use our commercially reasonable efforts to keep a registration statement effective, subject to certain exceptions, covering the issuance of the Common Stock issuable upon the exercise of the Warrants. If the registration statement ceases to be effective for any reason at the time of exercise of any Warrants, the right to exercise Warrants shall be automatically suspended until such registration statement becomes effective (any such period, an &#8220;Exercise Suspension Period&#8221;). The Company shall provide notice by press release, with a copy to the Warrant Agent, of any Exercise Suspension Period. No Early Expiration Price Condition Date, and no calculation of the VWAP for purposes of determining the Early Expiration Price Condition Date, shall occur during any Exercise Suspension Period. If the Expiration Date would otherwise fall in an Exercise Suspension Period, notwithstanding anything to the contrary in the Warrant Agreement, the Expiration Date shall be extended by the number of days included in such Exercise Suspension Period. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 22-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Other </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A holder of unexercised Warrants, in his or her capacity as such, is not entitled to any rights of a holder of shares of Common Stock, including, without limitation, the right to vote or to receive dividends or other distributions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All expenses related to the registration and approval of the shares of Common Stock issuable upon exercise of the Warrants will be borne by the Company. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Anti-Dilution Adjustments </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrant Exercise Rate shall be subject to adjustment, without duplication, as follows, except that the Company shall not make any such adjustments if each holder has the opportunity to participate, at the same time and upon the same terms as holders of the shares of Common Stock and solely as a result of holding the Warrants in any of the transactions described below, without having to exercise such holder&#8217;s Warrants, as if such holder held a number of shares of Common Stock equal to the product (rounded down to the nearest whole multiple of a share of Common Stock) of (i) the Warrant Exercise Rate in effect on the record date for such transaction and (ii) the number of Warrants held by it on such record date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">(a) <u>Stock Dividends, Splits, Subdivisions, Reclassifications and Combinations</u>. If the Company shall (i)&#160;exclusively issue shares of Common Stock to all or substantially all holders of Common Stock as a dividend or distribution on shares of the Common Stock, (ii) subdivide or reclassify the issued and outstanding shares of Common Stock into a greater number of shares, or (iii) combine, consolidate or reclassify the issued and outstanding shares of Common Stock into a smaller number of shares, then the Warrant Exercise Rate shall be adjusted based on the following formula: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 199pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 17pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub> = </font>WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#215;</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">OS<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 199pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">OS<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 199pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 199pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">where: </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 24pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect at the open of business on the Ex-Date for such dividend or distribution, or at the open of business on the effective date of such subdivision, combination, consolidation or reclassification, as applicable;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect immediately prior to the open of business on the Ex-Date for such dividend or distribution, or immediately prior to open of business on the effective date of such subdivision, combination, consolidation or reclassification, as applicable;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">OS<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the number of shares of Common Stock outstanding immediately after, and solely as a result of giving effect to, such dividend, distribution, subdivision, combination, consolidation or reclassification, as applicable;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">OS<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the number of shares of Common Stock outstanding immediately prior to the open of business on the Ex-Date for such dividend or distribution or immediately prior to the open of business on the effective date of such subdivision, combination, consolidation or reclassification, as applicable (before giving effect to any such dividend, distribution, or subdivision, consolidation, combination or reclassification, as applicable).</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any adjustment made under this provision shall become effective at the open of business on such Ex-Date for such dividend or distribution, or at the open of business on the effective date for such subdivision, consolidation, combination or reclassification, as applicable. If an adjustment to the Warrant Exercise Rate is made in respect of any dividend, distribution, subdivision, consolidation, combination or reclassification of the type described in this provision but such dividend, distribution, subdivision, consolidation, combination or reclassification is not so paid or made, the Warrant Exercise Rate shall be readjusted, effective as of the date the Board of Directors determines not to pay or make such dividend, distribution, subdivision, consolidation, combination or reclassification, to the Warrant Exercise Rate that would then be in effect at such time had no such adjustment been made. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">(b) <u>Rights Issues. </u>If the Company issues to all or substantially all holders of the Common Stock any rights, options or warrants entitling them, for a period of not more than 45 calendar days after the announcement date of such </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 23-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">issuance, to subscribe for or purchase shares of the Common Stock at a price per share that is less than the arithmetic average of the Last Reported Sale Prices of the Common Stock on each Trading Day comprised in the period of 10&#160;consecutive Trading Days immediately preceding the date of announcement of such issuance, the Warrant Exercise Rate shall be increased based on the following formula: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 17pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub> = </font>WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#215;</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">OS<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> + </font>X</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">OS<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> + </font>Y</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><u>where:</u></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 24pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect at the open of business on the Ex-Date for such issuance; </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect immediately prior to the open of business on the Ex-Date for such issuance; </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">OS<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the number of shares of Common Stock outstanding immediately prior to the open of business on the Ex-Date for such issuance; </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">X<font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">Y<font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the arithmetic average of the Last Reported Sale Prices of the Common Stock on each Trading Day comprised in the period of 10 consecutive Trading Days immediately preceding the date of announcement of the issuance of such rights, options or warrants.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any adjustment to the Warrant Exercise Rate made under this provision shall be made whenever any such rights, options or warrants are issued and shall become effective at the open of business on the Ex-Date for such issuance. To the extent that shares of the Common Stock are not delivered after the expiration of such rights, options or warrants, the Warrant Exercise Rate shall be decreased to the Warrant Exercise Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered. If an adjustment to the Warrant Exercise Rate is made in respect of any such issuance of rights, options or warrants but such rights, options or warrants are not so issued, the Warrant Exercise Rate shall be readjusted, effective as of the date the Board of Directors determines not to issue such rights, options or warrants, to the Warrant Exercise Rate that would then be in effect at such time had no such adjustment been made. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For purposes of this provision, in determining whether any rights, options or warrants entitle the holders of the Common Stock to subscribe for or purchase shares of the Common Stock at less than such arithmetic average of the Last Reported Sale Prices of the Common Stock on each Trading Day comprised in the period of 10 consecutive Trading Days immediately preceding the date of announcement for such issuance, and in determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received by the Company for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Board of Directors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">(c) <u>Other Distributions and Spin-Offs</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">(i) <u>Distributions Other than Spin-Offs.</u> If the Company makes a distribution to all or substantially all holders of its Common Stock, of its capital stock, evidences of indebtedness, other assets or property of the Company, or rights, options or warrants to acquire its capital stock or other securities, excluding: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(1) any dividends, distributions or issuances described in the provisions above; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(2) any dividends or distributions paid exclusively in cash described in the provisions below; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(3) any dividends or distributions in connection with a business combination, reclassification, change, consolidation, merger, conveyance, transfer, sale, lease or other disposition resulting in the change in the securities or property receivable upon the exercise of a warrant; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 24-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(4) any rights issued pursuant to a shareholders&#8217; rights plan adopted by the Company, other than as described in clause (e) below; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(5) any Spin-Offs described below, </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">then the Warrant Exercise Rate shall be increased based on the following formula: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 17pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub> = </font>WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#215;</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">SP<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 168pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">SP<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#8211; </font>FMV</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 168pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">where: </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 24pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect at the open of business on the Ex-Date for such distribution; </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect immediately prior to the open of business on the Ex-Date for such distribution; </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">SP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the arithmetic average of the Last Reported Sale Prices of the Common Stock on each Trading Day comprised in the period of 10 consecutive Trading Days immediately preceding the Ex-Date for such distribution; and </div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">FMV<font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Fair Market Value, as of the open of business on the Ex-Date for such distribution, of the shares of capital stock, evidences of indebtedness, assets or property of the Company, cash, rights or warrants distributed with respect to each outstanding share of Common Stock.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any adjustment to the Warrant Exercise Rate under this provision shall become effective at the open of business on the Ex-Date for such distribution. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">(ii) <u>Spin-Offs</u>. With respect to an adjustment pursuant to this provision where there has been a payment of a dividend or other distribution by the Company to all or substantially all holders of its Common Stock in shares of capital stock of any class or series, or similar equity interests, of or relating to a subsidiary or other business unit of the Company that will be, upon distribution, listed or quoted on a U.S. national or regional securities exchange (a&#160;&#8220;Spin-Off&#8221;), then the Warrant Exercise Rate shall be increased based on the following formula: </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 17pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub> = </font>WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#215;</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">FMV<font style="font-style: normal;"> + </font>SP<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 168pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">SP<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 168pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">where:</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 24pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect at the open of business on the Ex-Date of the Spin-Off;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect immediately prior to the open of business on the Ex-Date of the Spin-Off;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">FMV<font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the arithmetic average of the Last Reported Sale Prices of the capital stock or similar equity interest distributed to holders of the Common Stock (determined by reference to the definition of Last Reported Sale Price as if references therein to Common Stock were to such capital stock or similar equity interest) applicable to one share of Common Stock on each day which is a Trading Day for both the Common Stock and the capital stock or similar equity interest so distributed (each, a &#8220;Valuation Trading Day&#8221;) comprised in the period of 10 consecutive Valuation Trading Days commencing on the Ex-Date for such Spin-Off (or, if such Ex-Date is not a Valuation Trading Day, commencing on the immediately following Valuation Trading Day) (such period, the &#8220;Valuation Period&#8221;); and</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">SP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the arithmetic average of the Last Reported Sale Prices of the Common Stock on each Trading Day comprised in the Valuation Period.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 25-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any adjustment to the Warrant Exercise Rate under this provision shall be made immediately after the close of business on the last day of the Valuation Period, but shall become effective at the open of business on the Ex-Date for the Spin-Off. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an adjustment to the Warrant Exercise Rate is made in respect of any distribution of the type described in this provision but such distribution is not so made, the Warrant Exercise Rate shall be readjusted, effective as of the date the of Directors determines not to make such distribution, to the Warrant Exercise Rate that would then be in effect at such time had no such adjustment been made. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">(d) <u>Cash Dividends or Distributions</u>. If any cash dividend or distribution is paid to all or substantially all holders of Common Stock, then the Warrant Exercise Rate shall be increased based on the following formula: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 17pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub> = </font>WER<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#215;</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">SP<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; height: 17pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.76pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">SP<font style="font-style: normal;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub> &#8211; </font>C</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">where:</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 24pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect at the open of business on the Ex-Date for such dividend or distribution; and</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">WER<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the Warrant Exercise Rate in effect immediately prior to the open of business on the Ex-Date for such dividend or distribution;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">SP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub><font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the arithmetic average of the Last Reported Sale Prices of the Common Stock on each Trading Day comprised in the period of ten consecutive Trading Days immediately preceding the Ex-Date for such dividend or distribution;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: right;">C<font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">=</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 415pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">the amount in cash per share the Company distributes to holders of the Common Stock;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 415pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any adjustment to the Warrant Exercise Rate made under this provision shall become effective at the open of business on the Ex-Date for such dividend or distribution. If an adjustment to the Warrant Exercise Rate is made in respect of any dividend or distribution of the type described in this provision but such dividend or distribution is not so paid, the Warrant Exercise Rate shall be readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution, to the Warrant Exercise Rate that would then be in effect at such time had no such adjustment been made. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">(e) <u>Shareholder Rights Plan</u>. If the Company has a shareholder rights plan in effect upon exercise of any Warrant, each share of Common Stock, if any, issued upon such exercise shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common Stock issued upon such exercise shall bear such legends, if any, in each case as may be provided by the terms of any such shareholder rights plan, as the same may be amended from time to time. However, if, prior to any exercise, the rights have separated from the shares of Common Stock in accordance with the provisions of the applicable shareholder rights plan so that the holders of Warrants would not be entitled to receive any rights in respect of Common Stock, if any, issuable upon exercise, the Warrant Exercise Rate shall be adjusted at the time of separation as if the Company had made a distribution to all holders of its Common Stock, subject to readjustment in the event of the expiration, termination or redemption of such rights. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All adjustments to the Warrant Exercise Rate shall be made by the Calculation Agent to the nearest whole multiple of 0.00001 (with 0.000005 being rounded upwards) share of Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding anything to the contrary in the Warrant Agreement or the Warrants, (i) if the provisions of the Warrant Agreement shall require that an adjustment be made to the Warrant Exercise Rate in respect of any distribution or other relevant event, and the shares of Common Stock issuable in respect of any exercise are entitled to participate in such distribution or other relevant event, such adjustment shall not be given effect for the purpose of such exercise of Warrants and (ii) if the Exercise Date in respect of any exercise of Warrants falls after the record date for any Spin-Off and on or before the last day of the relevant Valuation Period, delivery of the shares of Common Stock issuable (or amount of cash payable, as applicable) pursuant to such exercise shall occur as soon as practicable after the last day of such Valuation Period. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 26-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any adjustments described above shall be made successively whenever an event referred to therein shall occur. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Business Combinations and Reorganizations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of a merger, consolidation, amalgamation, statutory share exchange or similar transaction that requires the approval of the Company&#8217;s stockholders (a &#8220;Business Combination&#8221;) or reclassification of Common Stock, other than a reclassification of Common Stock referred to in &#8220;Anti-dilution Adjustments&#8221; above, the right of a Warrant holder to receive Common Stock upon exercise of a Warrant will be converted into the right to exercise a Warrant to acquire, per each Warrant, the number of shares or other securities or property (including cash) that a number of shares of Common Stock equal to the Warrant Exercise Rate (in effect at the time of such Business Combination or reclassification) immediately prior to such Business Combination or reclassification would have been entitled to receive upon consummation of such Business Combination or reclassification (the amount of such shares, other securities or property in respect of a share of Common Stock being herein referred to as a &#8220;Unit of Reference Property&#8221;). If the Business Combination causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), then the composition of the Unit of Reference Property into which the Warrants will be exercisable will be deemed to be the weighted average of the types and amounts of consideration actually received by the holders of Common Stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Certain Definitions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;Business Day&#8221; means each day that is not a Saturday, Sunday or a day on which banking institutions are allowed by law, regulation or executive order to be closed in the State of New York. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;Last Reported Sale Price&#8221; means, with respect to the Common Stock (or other security), on any given day, the last sale price, regular way, or, in case no such sale takes place on such day, the average of the last bid price and last ask price (or, if more than one in either case, the arithmetic average of the average last bid prices and the average last prices), regular way, of the Common Stock (or such other security, as the case may be) as reported in composite transactions for the Exchange on such day, without regard to after-hours or extended market trading, <font style="font-style: italic;">provided</font> that if the Common Stock (or such other security, as the case may be) is not listed on the Exchange on any date of determination, the Last Reported Sale Price of the Common Stock (or such other security, as the case may be) on such date of determination means the closing sale price as reported in the composite transactions for the principal U.S.&#160;national or regional securities exchange on which the Common Stock (or such other security, as the case may be) is so listed or quoted, or, if no closing sale price is reported, the last reported sale price on the principal U.S.&#160;national or regional securities exchange on which the Common Stock (or such other security, as the case may be) is so listed or quoted, or, if the Common Stock (or such other security, as the case may be) is not so listed or quoted on a U.S. national or regional securities exchange, the last quoted bid price for the Common Stock (or such other security, as the case may be) in the over-the-counter market as reported by OTC Markets Group Inc. or a similar organization, or, if that bid price is not available, the Last Reported Sale Price of the Common Stock (or such other security, as the case may be) on that date shall mean the Fair Market Value per share of Common Stock (or such other security, as the case may be) as of such day. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Calculations in respect of the Warrants; Calculation Agent </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The company will appoint a calculation agent (the &#8220;Calculation Agent&#8221;), which will be responsible for making all calculations and other determinations specified to be made by it under this Warrant Agreement and the Warrants, and any calculations and determinations not so specified will be the responsibility of the Company or an Independent Advisor (as defined in the Warrant Agreement). All calculations and determinations will be made in good faith and, absent manifest error, such calculations and determinations will be final and binding on holders of the Warrants and the Warrant Agent. The Company will provide with reasonable notice a schedule of the calculations and determinations made by the Company, the Calculation Agent or an Independent Advisor, as applicable, to the Warrant Agent. The Warrant Agent is entitled to rely conclusively upon the accuracy of the calculations and determinations made by the Company and the Calculation Agent without independent verification. All calculations are subject to rounding as described in the Warrant Agreement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 27-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOC"><!--Anchor--></a>DESCRIPTION OF CAPITAL STOCK </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following information describes our common stock, par value $0.0001 per share, as well as certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws. This description is only a summary. For a complete statement of the terms and rights of the common stock, you should also refer to our amended and restated certificate of incorporation and amended and restated bylaws which have been publicly filed with the SEC, as well as the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;). See &#8220;Where You Can Find More Information; Incorporation by Reference.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Capital Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.0001 per share, and 5,000,000 shares of preferred stock, par value $0.0001 per share. Our board of directors may establish the rights, powers and preferences of undesignated preferred stock from time to time. Our board of directors is authorized, without stockholder approval, except as required by the listing standards of the New York Stock Exchange, to issue additional shares of our authorized capital stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Common Stock </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Voting Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The holders of our common stock are entitled to one vote per share on all matters to be voted upon by the stockholders. Our amended and restated certificate of incorporation prohibits cumulative voting. Pursuant to our amended and restated bylaws, the election of directors shall be decided by a plurality vote of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. With respect to matters other than the election of directors, if a quorum is present, the affirmative vote of a majority of the shares represented and voting at a duly held meeting (which shares voting affirmatively also constitute at least a majority of the required quorum) shall be the act of the stockholders, unless the vote of a greater number or a vote by classes is required by law, by our amended and restated certificate of incorporation or by our amended and restated bylaws. The holders of a majority of the shares issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. Our amended and restated certificate of incorporation prohibits stockholders from taking action by written consent in lieu of a meeting. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 19pt; margin-left: 0pt; text-align: left;">Dividend Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have never declared or paid any cash dividends on our common stock. We currently intend to retain any earnings for future growth and do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our results of operations, financial conditions, contractual and legal restrictions and other factors the board deems relevant. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 19pt; margin-left: 0pt; text-align: left;">Preemption, Conversion, and Redemption Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of our common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption provisions applicable to the common stock. The outstanding shares of common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred stock that we may designate and/or issue in the future. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Board of Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of directors is fixed by, or in the manner provided in, our amended and restated certificate of incorporation and amended and restated bylaws. Commencing at the 2025 annual meeting of stockholders, all of our directors elected at an annual meeting of stockholders shall hold office for a term that expires at the next annual meeting of stockholders (or until their respective successors shall have been elected and qualified or until their earlier death, resignation or removal). The term of each director serving as of and immediately following the date of the 2024&#160;annual meeting of stockholders shall expire at the 2025 annual meeting of stockholders, notwithstanding that such director may have been elected for a term that extended beyond the date of the 2025 annual meeting of stockholders. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 28-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Anti-Takeover Effects of Certain Provisions of Delaware Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provisions of Delaware law and of our amended and restated certificate of incorporation and amended and restated bylaws could make the acquisition of the Company through a tender offer, a proxy contest or other means more difficult and could make the removal of incumbent officers and directors more difficult. These provisions can discourage inadequate takeover bids and encourage persons seeking to acquire control of the Company to first&#160;negotiate with our board of directors. We believe that the benefits provided by our ability to negotiate with the proponent of an unsolicited proposal would outweigh the disadvantages of discouraging these proposals. We believe the negotiation of an unsolicited proposal could result in terms more favorable to our stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are subject to Section&#160;203 of the DGCL, which prohibits persons deemed to be &#8220;interested stockholders&#8221; from engaging in a &#8220;business combination&#8221; with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation&#8217;s voting stock. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this law may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary of the provisions of Section&#160;203 of the DGCL does not purport to be complete and is qualified in its entirety by reference to our amended and restated certificate of incorporation, our amended and restated bylaws, and the DGCL. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Anti-Takeover Provisions of the Company&#8217;s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain provisions in our amended and restated certificate of incorporation and amended and restated bylaws summarized below could discourage, delay or prevent a change in control of our Company or changes in our management that the stockholders of our Company may deem advantageous. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our amended and restated certificate of incorporation, the board of directors may issue, without further stockholder approval, shares of preferred stock in one or more series and may also set forth the voting powers, full or limited or none, of each such series of preferred stock, which the board could use to implement a stockholder rights plan (also known as a &#8220;poison pill&#8221;). The board of directors shall fix the designations, preferences and relative, participating, optional or other special rights of each such series of preferred stock and the qualifications, limitations or restrictions of such powers, designations, preferences or rights. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">No Action by Written Consent </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our amended and restated certificate of incorporation and amended and restated bylaws, stockholders of the Company may not take action by written consent in lieu of a meeting. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Special Meetings of Stockholders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our amended and restated bylaws, special meetings of our stockholders may be called only by the board of directors, the chairman of the board, the chief executive officer, or the president of the Company. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Advance Notice Requirements for Stockholders Proposals and Director Nominations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals to be brought before a stockholder meeting and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Board of Directors and Vacancies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The authorized number of directors on the board of directors will be established from time to time by resolution of the board of directors. Vacancies arising through death, resignation, removal, an increase in the number of directors or otherwise may be filled only by a majority of the directors then in office, though less than a quorum, or by a sole&#160;remaining director. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 29-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_109-desc_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Amendment of Our Amended and Restated Bylaws </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The board of directors is expressly authorized to make, alter or repeal our amended and restated bylaws. Our amended and restated bylaws provide that stockholders are permitted to amend the amended and restated bylaws only with the approval of the holders of sixty-six and two-thirds percent (66 2/3%) of the voting power of outstanding capital stock entitled to vote at an election of directors. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Forum Selection Clause </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the amended and restated certificate of incorporation and the amended and restated bylaws, unless the Company consents in writing to the selection of an alternative forum, the sole and exclusive forum for making certain types of claims will be a state or federal court located within the State of Delaware. This provision applies to (i) any derivative action or proceeding brought on behalf of the company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or other employee of the Company to the Company or its stockholders, (iii) any action asserting a claim against the company or any director or officer or other employee of the Company arising pursuant to any provision of the DGCL or our amended and restated certificate of incorporation and the amended and restated bylaws, or (iv) any action asserting a claim against the company or any director or officer or other employee of the company governed by the internal affairs doctrine. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our transfer agent and registrar for our common stock is Computershare Trust Company, N.A. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Listing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our common stock is listed on the New York Stock Exchange under the trading symbol &#8220;BBBY.&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 30-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_110-tax_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMUF"><!--Anchor--></a>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following discussion is a summary of the material U.S. federal income tax consequences to U.S. holders (as defined below) of the Warrant Distribution and the ownership and exercise of Warrants received in the Warrant Distribution, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S.&#160;federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), Treasury regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a U.S. holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the Warrant Distribution and the ownership and exercise of Warrants received in the Warrant Distribution. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This discussion is limited to U.S. holders that hold our Common Stock and the Warrants as &#8220;capital assets&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a U.S. holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on net investment income and the alternative minimum tax. In addition, it does not address consequences relevant to U.S. holders subject to special rules, including, without limitation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. expatriates and former citizens or long-term residents of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">banks, insurance companies, and other financial institutions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">brokers, dealers, or traders in securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-exempt organizations or governmental organizations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons deemed to sell our common stock under the constructive sale provisions of the Code; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-qualified retirement plans; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">persons subject to special tax accounting rules as a result of any item of gross income with respect to the stock being taken into account in an applicable financial statement. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an entity treated as a partnership for U.S. federal income tax purposes holds shares of Common Stock or Warrants, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them of the Warrant Distribution and the ownership and exercise of Warrants received in the Warrant Distribution. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE WARRANT DISTRIBUTION AND THE OWNERSHIP AND EXERCISE OF WARRANTS RECEIVED UNDER THE WARRANT DISTRIBUTION ARISING UNDER U.S.&#160;FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL, OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 31-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_110-tax_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For purposes of this discussion, a U.S. holder is a beneficial owner of shares of Common Stock receiving Warrants or a beneficial owner of Warrants that is: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual who is a citizen or resident of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a corporation (including an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or of a political subdivision thereof (including the District of Columbia); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an estate whose income is subject to U.S. federal income taxation, regardless of its source; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a trust if: (a) a U.S. court is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (b) it has a valid election in place to be treated as a U.S. person. </div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 0pt; text-align: left;">Tax Consequences of the Warrant Distribution </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrant Distribution is intended to be treated as a non-taxable distribution under Section&#160;305(a) of the Code. If, however, the Warrant Distribution were treated as a distribution subject to Section&#160;305(b) of the Code, a U.S.&#160;holder&#8217;s shares of Common Stock would be treated for U.S. federal income tax purposes as receiving a distribution equal to the fair market value of the Warrants. In such case, the Warrant Distribution would be taxable as a dividend to the extent paid out of our current or accumulated earnings and profits (as determined under U.S.&#160;federal income tax principles). The remainder of this discussion assumes that the Warrant Distribution will be treated as a non-taxable distribution under Section&#160;305(a) of the Code. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 0pt; text-align: left;">Tax Basis and Holding Period in the Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the fair market value of the Warrants received in the Warrant Distribution is less than 15% of the fair market value of a U.S. holder&#8217;s shares of Common Stock on the date of the Warrant Distribution, the Warrants received will be allocated a zero tax basis for U.S. federal income tax purposes, unless such U.S. holder elects to allocate tax basis between the existing shares of Common Stock and the Warrants in proportion to their relative fair market values determined on the date of the Warrant Distribution. A U.S. holder that elects to allocate tax basis between such holder&#8217;s existing shares of Common Stock and Warrants must make this election on a statement included with such holder&#8217;s tax return for the taxable year in which the Warrant Distribution occurs. Such an election is irrevocable. If, however, the fair market value of the Warrants received in the distribution is 15% or more of the fair market value of a U.S. holder&#8217;s shares of Common Stock on the date of the Warrant Distribution, such holder&#8217;s tax basis in the existing shares of Common Stock must be allocated between the existing shares of Common Stock and the Warrants in proportion to their relative fair market values determined on the date of the Warrant Distribution. Based upon the terms of the Warrants and the Warrant Distribution, the Company intends to take the position that the fair market value of the Warrants received in the Warrant Distribution is less than 15% of the fair market value of a U.S. holder&#8217;s shares of Common Stock on the date of the Warrant Distribution. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A U.S. holder&#8217;s holding period for the Warrants will include the holding period for the shares of Common Stock with respect to which the Warrants were received. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Possible Constructive Distributions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of shares of Common Stock that a holder is entitled to receive upon exercise of a Warrant and the Exercise Price of the Warrant are subject to certain anti-dilution adjustments. Certain of these adjustments (including adjustments as a result of a distribution to holders of shares of Common Stock) could cause a holder to be deemed to receive a &#8220;constructive distribution&#8221; that is includible in income for U.S. federal income tax purposes. U.S. holders should consult their tax advisors regarding the possibility of constructive distributions with respect to the Warrants. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Lapse of a Warrant </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Warrants received in the Warrant Distribution expire while a U.S. Holder owns the shares of Common Stock with respect to which the Warrants were distributed, such U.S. holder generally should not recognize any gain or loss upon that expiration. If a U.S. holder has tax basis in the Warrants and allows the Warrants to expire while continuing to hold the shares of Common Stock with respect to which the Warrants were distributed, the tax basis of such shares of Common Stock will be restored to the tax basis of such shares of Common Stock immediately </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 32-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_110-tax_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">before the receipt of the Warrants in the Warrant Distribution. If the Warrants expire after a U.S. holder has disposed of the shares of Common Stock with respect to which the Warrants were distributed, certain aspects of the tax treatment of the expiration are unclear, and such holder should consult its tax advisor regarding its ability to recognize a loss (if any) on the expiration of the Warrants. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Exercise of a Warrant </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">U.S. holders should not recognize any gain or loss with respect to a Warrant upon the exercise of the Warrant. In general, shares of Common Stock acquired pursuant to the exercise of a Warrant will have a tax basis equal to the U.S. holder&#8217;s tax basis in the Warrant, if any, increased by the price paid to exercise the Warrant. The holding period for the shares of Common Stock received upon exercise of the Warrant will generally begin on the date of exercise of the Warrant. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Sale or Other Taxable Disposition of a Warrant </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The gain or loss a U.S. holder realizes on the sale or other taxable disposition of a Warrant generally will be a capital gain or loss, and will be long-term capital gain or loss if the U.S. holder has held the Warrants for more than one year. The amount of a U.S. holder&#8217;s gain or loss will equal the difference between the U.S. Holder&#8217;s tax basis in the Warrants disposed, if any, of and the amount realized on the disposition. For non-corporate taxpayers, including individuals, long-term capital gains are generally eligible for reduced rates of taxation. In addition, certain limitations exist on the deductibility of capital losses. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Information Reporting and Backup Withholding </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In general, information reporting may apply to dividends paid to a U.S. holder and to the proceeds of the sale or disposition of the Warrants or Common Stock unless the U.S. holder is an exempt recipient. Backup withholding may apply to such payments if the U.S. holder fails to provide a taxpayer identification number and a certification of exempt status by providing an IRS Form&#160;W-9, or has been notified by the IRS that it is subject to backup withholding (and such notification has not been withdrawn). Backup withholding is not an additional tax. Any amounts withheld under backup withholding rules will be allowed as a refund or credit against a U.S. holder&#8217;s U.S.&#160;federal income tax liability, provided that the required information is timely furnished to the IRS. All U.S.&#160;holders should consult their tax advisors regarding the application of information reporting and backup withholding to them. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 33-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_111-legal_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The validity of our Common Stock offered hereby will be passed upon for us by Bryan Cave Leighton Paisner&#160;LLP, St. Louis, Missouri. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tEX"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The consolidated financial statements of Bed Bath &amp; Beyond, Inc. as of December 31, 2024 and 2023, and for each of the years in the three-year period ended December 31, 2024, and management&#8217;s assessment of the effectiveness of internal control over financial reporting as of December 31, 2024 have been incorporated by reference herein and in the registration statement in reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of Medici Ventures, L.P. as of September 30, 2022 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form 10-K) of Bed Bath &amp; Beyond, Inc., for the year ended December 31, 2024, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of Medici Ventures, L.P. as of September 30, 2023 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form 10-K) of Bed Bath &amp; Beyond, Inc., for the year ended December 31, 2024, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of Medici Ventures, L.P. as of September 30, 2024 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form 10-K) of Bed Bath &amp; Beyond, Inc., for the year ended December 31, 2024, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of tZERO Group, Inc. as of December 31, 2023 and 2022 and for the years then ended have been incorporated by reference herein and in the registration statement in reliance upon the report of Baker Tilly US, LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 34-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_111-legal_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our filings with the SEC are available to the public through the SEC&#8217;s Internet site at www.sec.gov. Our annual, quarterly and current reports and amendments to those reports are also available over the Internet on our Investor Relations website at https://investors.beyond.com All internet addresses provided in this prospectus are for informational purposes only and are not intended to be hyperlinks. In addition, the information on, or accessible through, our Internet site, or any other Internet site described herein, is not a part of, and is not incorporated or deemed to be incorporated by reference in, this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have filed with the SEC a registration statement under the Securities Act relating to the offering of these securities. The registration statement, including the attached exhibits, contains additional relevant information about us and the securities offered by this prospectus. This prospectus does not contain all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information about us and the shares of common stock offered hereby, we refer you to the registration statement and the exhibits and schedules thereto. Statements contained, or incorporated by reference, in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement (or any document incorporated by reference therein) are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the registration statement (or such other document incorporated by reference therein). The registration statement and the documents referred to below under &#8220;Information Incorporated by Reference&#8221; are also available on the SEC&#8217;s website and the investor relations section of our website, each as set forth above. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">29<br></div></div></div>
<!--End Page 35-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20056677x2_424b2_112-incorp_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tIIR"><!--Anchor--></a>INFORMATION INCORPORATED BY REFERENCE </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The SEC allows us to incorporate by reference into this prospectus certain information we file with it, which means that we can disclose important information by referring you to those documents. The information incorporated by reference is considered to be a part of this prospectus, and information that we file later with the SEC will automatically update and supersede information contained in this prospectus. We incorporate by reference the documents listed below that we have previously filed with the SEC (excluding any Forms 8-K or portions of any Form&#160;8-K that are not deemed &#8220;filed&#8221; pursuant to the General Instructions of Form&#160;8-K): </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000024/byon-20241231.htm">February&#160;25, 2025</a> </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Quarterly Reports on Form&#160;10-Q for the quarter ended March&#160;31, 2025, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000041/byon-20250331.htm">April&#160;29, 2025</a>, the quarter ended June&#160;30, 2025, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000057/byon-20250630.htm">July&#160;29, 2025</a> and the quarter ended September 30, 2025, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000078/byon-20250930.htm">October 27, 2025</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The information specifically incorporated by reference into our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2023 from our definitive Proxy Statement on Schedule 14A, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125010811/ny20044387x2_def14a.htm">March&#160;28, 2025</a>; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Current Reports on Form&#160;8-K filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000006/ostk-20250131.htm">January&#160;31, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000010/ostk-20250130.htm">February&#160;3, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000012/ostk-20250205.htm">February&#160;5, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000015/ostk-20250221.htm">February&#160;24, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000027/ostk-20250308.htm">March&#160;10, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000029/ostk-20250314.htm">March&#160;17, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125018409/ef20048777_8-k.htm">May&#160;12, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000045/byon-20250515.htm">May&#160;21, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125032363/ef20054350_8k.htm">August&#160;22, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125035644/ef20055884_8k.htm">September&#160;22, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125035850/ef20055961_8k.htm">September&#160;23, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125037599/ef20056742_8k.htm">October 8, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125042343/ef20059186_8k.htm">November 14, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125043247/ef20059982_8k.htm">November 25, 2025</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036125043886/ef20060252_8k.htm ">December 2, 2025</a> (except for the information furnished under Items 2.02 or 7.01 and the exhibits furnished thereto); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The description of our common stock contained in the Registration Statement on Form&#160;8-A12B, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036123049418/ny20013062x1_8a12b.htm">October&#160;25, 2023</a>, and any amendment or report filed with the SEC for the purpose of updating such description. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We also incorporate by reference into this prospectus additional documents that we may file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the completion or termination of the offering, but excluding any information that is (or is deemed to be) furnished to and not filed with the SEC. Any statements contained in a previously filed document incorporated by reference into this prospectus is deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, or in a subsequently filed document also incorporated by reference herein, modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to be a part of this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You should not assume that the information in this prospectus or any document incorporated by reference herein is accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will provide to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral request, at no cost to the requester, a copy of any or all of the information that is incorporated by reference in this prospectus, other than exhibits to such documents, unless such exhibits have been specifically incorporated by reference therein. Requests for such documents should be directed to: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">Bed Bath &amp; Beyond, Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">433 W. Ascension Way, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Murray, Utah 84123 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Attn: Investor Relations <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(801) 947-3100 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You may also access the documents incorporated by reference in this prospectus on our Investor Relations website at https://investors.beyond.com. The information on, or accessible through, our website, or any other website described herein, is not a part of, and is not incorporated or deemed to be incorporated by reference in, this prospectus, or the registration statement of which it form a part. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">30<br></div></div></div>
<!--End Page 36-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20056677x2_424b2_300-bcv_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_block-frill" style="width: 456pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 150.75pt; text-align: center;"><img style="height: 93px; width: 255px;" src="logo_bedbathbeyond.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">COMMON STOCK </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">PROSPECTUS</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 246.5pt; text-align: center;">December 3, 2025</div></div></div><div class="BRDSX_block-frill" style="width: 456pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 37-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_bedbathbeyond.jpg
<TEXT>
begin 644 logo_bedbathbeyond.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M0_\ $5O\&_\ HU;XD_\ A8>%_P#Y'H_XBM_@W_T:M\2?_"P\+_\ R/7\L_\
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M9*55)\UV[^\W9L^R?^(K?X-_]&K?$G_PL/"__P CT?\ $5O\&_\ HU;XD_\
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M[$UG(\R-)-JC[6-P&[&[:,XZ5./^#57X_@J1^T-\/A@Y);1==(Q@YR%N2?R
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MH ?FF:6X9B2I-?JS_P &O_[8W_"3_#[XB_L@>+=:>?5? 5T/&WPWMKJ0*/\
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MCU?31+''J<^AZKHRVNG:C)""9FLTELKBT23:4$L14L"PKZZ_X+O_ /!,R_\
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M<R6,L\!5F@>YM[>8J>-\*D<\C^O/_@[*_P"01^QU_P!?_P 6?_23PA7YI?\
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M\3M2O-;_ &8OB!KUM#KEE/)+<3_#;5]0E%I_PEVA6YWB.Q6:03>(-/@B4W4
MEO$22ZA7=Z>=8O$\;<(NMPOF5>-53G4Q6715*G4JX>,'.IA)STJ1J134HOFY
M:R7([QFI'%EE"'#N=O#9U!UJ+O+#2JP@Z%!J2G3KTW&*YX049)N;YX-1E;FB
M[_Z.21D!<D<.#]<?7_/:K-<=X3\6>'O&WAO0_%GA;5K36O#VOV-GJNC:OIEP
MMQ9:CI]_!%<6MU!-&Q#PRQ2(R$\C=A@&) ZEYD0 .Q!YZ$Y(XYZ$_P">,]!_
M-7+.#]G*$XR@W!QFG&HI*5I1E%V=U*_1-KIL?KL9QG!58RC*G4490G%ITY1<
M8V<7=JUK=7KZHL45^"'[8'_!>C]FW]D?]J[0OV>-:TK5O&NB:?!=6WQ;\:>%
M;IKJ3X=:]/-"FDZ8VERI$FJB"*66[U];*Z>XL81"L,4]PLEO7[)_ _XW_##]
MH?X=:)\5/A!XPTOQSX%\1(\FE:_I,DKV\_E[5FA>.>.*>"X@DS'/!-%')'("
M"@XKU<;D6<9=AL/C,=EV+PV%Q45*A7JT9PIS4ES1]YJR<HN\4[.2U6AQX?,L
M#BZ];#8?$PJU\.[5:<;WCT;3:2DD_=;BVD]'JSURBBBO*.XK/_K&^C_^BA7^
M:K_P<%_\I3/CL.QTSX<?^H#X=']:_P!*I_\ 6-]'_P#10K_-5_X."@3_ ,%3
M?CK_ -@SX<?^H#X=/]*_5O"&W^L6.OL\JL_1X_!I_@?&<<ZY;A?^P^'_ *C2
M/Z5O^#7+C]@WQZ!_T<!XI'O_ ,BQX1/\Z_I<P?4_I_A7\TG_  :Z#'[!WCXD
MC_DX+Q2O?J?"_A+CI[?D0?7']+E?)\=0BN+L]5M(XN*2UT7U>B[?>V>KPQ[N
M0Y<FK/V4]&NGM9)?C^'D,"8S\S<G/.T_S7'Y\^]?S=?\'.?PT\/>(OV$-'^(
M%Y8P2>(?A]\4?"<>B:BZJ;FVM?$MP^FZG;12%6<1W)2U:6,,JOY2E@VP ?TB
M-*J@DAL $G"DD =>!D_AC)Z"OY"/^#H+]L?P8? /PW_8\\*:]8ZKXKU7Q''\
M0/B1I]E(TL_AW3=!6%/"UK>NJ&".?5+RZOYOL_F>='%9K)(@#QYVX!PM7%\7
M9+&ES*-/$.MB)0NHQPU.E/VCJ26T'>,6WO*48WU)XIE2CD./A5G"'M80ITO:
M26M:52'+RIW;DH\TE9-\L6UL?AE_P03\>ZQX)_X*<? 2TTRXFAM?&UQXF\&:
MS$C.$N=.OO#]_?QQ2HKJK*-0TVSD(964,H*INP1^^O\ P=;KCX#?LI]1GXI>
M-R>?3PM;D#ITZ ^M?B%_P;R?!O7?BC_P4A^'GBC3[5IM(^#FA^)/B'K]R4W0
M00R6<GAK38V<G"RRW^M+)'U.+9L#'(_;[_@ZW_Y(1^RHHY*_%'QP3[C_ (16
MV.?U!([$X'2OU7-Y4:GBGPU"#C.HL/.-=1=Y7=/%.FII;2<+./DTT?$X*-9\
M(9U"49>S>+HQH)[3M+"\[@]Y7E>^KUN?DG_P;+?\I(9_^R#_ !$_]._@ZO\
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MJ48\L:5K)O1[I2:/EL'@N,,!1]A@H>PI2G[1Q2I3O.2@I2O.+>JM^'G;FO\
MB+"\5_\ 1H.A?^'&O?\ Y34?\187BO\ Z-!T/T&/B->DY/'_ $!_\?I72_\
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M73[VZT\LXANS"1*(FW*&\O#8/!SP?Z-7_P"#IS]J:-$ ^!/PE51A5/V[Q!R
M 221*3DN6..@!P.Y/TV?^#46Q<[C^U5?<\#_ (H6UZ X'_,4;L/7WP.@3_B%
M#L/^CJK[_P (6V_^65?JV:<2>&^<585,SQ6!QM2@Y*A*O2Q+5.,N5.,HQHI2
M5N73F24DI='?Y+ 93Q9@(36%ISH^U4;J,HQY4N7E4XIRYIQ3<6^?=NUEHOEN
M;_@Z=_:LEBDC@^!_PCBF>-UBE:[\02K'(5.QVC\U-X5L$KN&<8S7QS\;/^#A
M#_@HI\7M-OM#L/B#H/PLT:]C>*1?A[X?ATS5D5U*N(]=NI+B_API(7R98R,
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MG75MWUZ[V\VVVWYGVR2222LDDDNU@HHHH _EP_X.H_\ DTGX&GL/C2V3Z?\
M%,ZF.?Q('U-?RF_\$M_VX-&_X)^_M46WQ^\0>#=0\<:=;>#?$_A671-,NH+.
M\)U^+3@MU'+<LD)$+6XW(W+*"% ;BO[^_P#@JC_P3HM_^"D/PB\%?"ZX^(LW
MPX'A#QC_ ,)<FIQ:4FK_ &QET^XL?LDEL\L&$Q/YF\2J0RC@]OP:/_!J+8R-
MN;]JF^!QQ_Q0EOCD \9U,^_KP!Z5^X<'<3<,X7A)9+G&84:,ZE7&T\1AIQQ'
M-4PV-YJ-2//3IR2O2G=24KIM6LTV?FO$.2YUB,]IX[+Z*E&E.E7HUE*-X5J=
M*G&%XSC:\)PYTO>4M(NUST,_\'6?PI.,?LT^-<<]=?T8<;CC/[X<[<9[YS7D
MGQ2_X.L-7ETV>S^$/[+\%O?S6]Q'%JGCCQ65AL[EHG6WN%L-&AN#=K%*T;E)
MKB%'"LC$;@3L_P#$*'8_]'57W_A"VW_RRKJO#/\ P:E>!?[15O%_[4/BNYTO
M),D&@^%=+MKQE!7")+>7<\2$X.6,3$9!'(&5?PAP]JO^\3BU*"I3QLTFN5M3
MC444^;2RL[V:=K*Y.''=2$H2JU;227[N.&AII?WG%-.S7*TU:VNMK?RU_M=?
MMT?M,_MT>-+7Q1\>O'=_XE^P33CPSX0L$-GX5\._;&A5X-$T6VQ%YTPA@C>Y
M<2W5P8T!8'BOW^_X(1?\$CO%]SXWTW]MS]J;PG/X-^'WP]MF\1?"OPIXNM/L
M=WX@U:WBBO(O&NIZ?=(#::+H<23SZ=Y^V6>]C2["".%"_P"^G[*7_!";]@O]
MEV_TGQ+!X N/BKXYTB;[1:>*?B?<#7OL\P! >UT(+'H414D2([V,TD<BAE<,
MNX?HY^TK\(O$7QA^ OQ'^#_@GQC_ ,*VU3QYX1U#PC:>*;"Q$TNA66J6[65X
M]E;*\:I)]BEEAMS&R-"2&5AVXL\\0LNJX2GD7#D'@,#6Y,/B,=5A[)4</)QA
M4]G1@I2DO97O)RBW[UH7:<=LHX4QD:L\PSB2JXB$9U*&&]HZTIU.2\'7JR2M
M).UX14HWM[S5[_YK?_!6C]K:?]LK]MGXJ_$>POKNX\#^'=4/@/X>6MS.LT%O
MX=\-8L6N[18V,<<.LWZ7&I84\K.FXY7 _JF_X-GOV-%^%'[-_B']I_Q=H3V'
MC;XW:B]CX7GOX EVGPWT=XGL+ZT9E#)9Z]J+W4@P3YT=A#(>-I/S%:?\&IVD
M-J5K+??M1ZM/8B\AENXE\$VT<]Q;"8-<1F<ZG)MEFC#IYV&VN^_!QQ_6?\(/
MA7X:^"OPO\ _"GP99I8>%_A]X7T;PIH5HI+>5I^C6$-E#N8Y9I)/*:61B69I
M)&8MG%7QKQ;DM7AW!Y%P[BU5450P^*E2A4A3^K4*,4X>_&#;G-1T5UR\R<MG
M)\/Y'C99Q4S/-<-.E.$93BY\C=2N^6$91LWI"*D]8K>*233/4%SM7/!VC('(
MSCGFG4@Z#/H*6OQH_0PI&.%8^@)_(4M(PRK ]""/TH _B@_X.A?V.Y=-\2?#
M#]LGPKIRKIVN0P?#3XC26UM''MU6#[1>>&M6O)(U4S27EK]LLVDE8N%LX4)(
M(%?!7_!O)^VA)^S5^V+!\)/$FHBS^'7[1EO:^&+X7$ZPV6G^-M.2:?PGJ4A;
M&7NB]]HVW(#O?0$C**!_=-^V=^RKX+_;-_9T^(?[/OCI4MM+\9:4T>E:Q]F2
MXN?#?B&VS)H_B*P1BN;S2YRSQKO02)))$[!'(K^9_P /_P#!K3<>$]?TCQ-X
M?_:UU:PU_0=4LM9TF_@\%6\4]IJ.F7<=Y8W$4R:H2DL,\,3@C)#+WY%?L_#G
M%7#^+X2Q/#W$>.6$JJG/#4:M>G.I"5&-I4''V:DU.$E&*322Y5)2NS\YSC(L
MRH9U',\GP_/S2IXBU-I)5^>*JTZG-)-0JQ<FY)2U;5K[_OM_P5:<2?\ !._]
MJ\KT_P"%1^(R ,$C_17&."1CY<CVK_- _9;!/[2/P'P"?^+J^ ^@_P"IBTVO
M]1[X\?LX:I\?/V2O&'[.'BCQBT.M>.?AN/!6N>-K>S433ZF^GQ6MUKBV0>--
MUS<))<RVXD"?O63=R"?YU/A9_P &OVG?#?XD^!/'S_M-:EJ7_"%>*M#\2KIO
M_"&V\ O3HNH07ZVOFC4W\I9C $9PK%0V<$BL> .)\ER/),YP>/Q<85ZN,J5<
M,H0G*G7A&E"G3<)VNE+E5^9+EON]B^*\FS+,\?@ZN%P_/!86G3JOGBG2J*JZ
MDHS4G%[R5G&]]=#^LW3/^0;9?]>=O_Z3QUL5F6=H+>RAME;<+>VBMR>1GRXU
M1L \C(&><XSP36G7X_)ISFT_M22_P\SE%O5ZM2VZ6\]/T*-U&*:M[L&_)\D4
MU\N4_CD_X.RN=)_8Z Y/V_XL<#D_\>GA'M7Q=_P:Q C]M7XP@@@_\,\ZN<8Y
MQ_PGG@KG'IP?RK^EW_@K#_P2HM?^"F5O\'[>;XI3?#1_A3>^)KD/#HT>L'5$
M\1V^E1.ACDN;80F :8I!WD$..#R5\@_X);?\$4K;_@G%\;?&GQ@M_C1<_$5O
M%?P\N/ @T>;P_%HZ6J76O:-K+7OG17-R92HTD1*@V8:0,20./U[!\3Y)1\.,
M3DTL=36;.C6H4\$X5N>;JXZE6<N?V;IKE@G)+G][:Z;L?"U,DS"?%G]HRI*.
M"]I3JQK)\VE/#J%I+2SE.RMLE>[O9'[SIT_X'_5JGH P /08HK\?2LDNU_Q/
MN^K?>WX)+] J)^OX?U-2TTKE@?0#Z]3C\/\ Z]$FU%V5[Z/R3>_R&K7U=K-/
MU::=C^6G_@Z<_P"34/@O_P!E<_\ <%>U^%O_  ;> C_@I#X/R,?\6_\ &77C
M_ERMZ_LB_P""I7_!..#_ (*/?"7P;\,Y_B+-\.1X1\8+XI34X=*35A>?Z)-:
M-:O \\!3Y)G9'$A"G@J0Q(^&O^"</_!!RR_8)_:*TOX^_P#"\[KQY-IF@ZMH
M<>B/X>ATJ.4:I$D+3&9;FY;$94DKA"<CGJ*_7LFXIR7!\ XS)\1B90S&>'S#
M#4Z"@Y<_UN5X34K<J2TNF[[]CX#-,ES"OQ-@\=0H^TPJKX.O4JN48JG]7<.>
M#3?,VU33BU%J[L[:']%M%%%?D1]\(0"1GT/]._\ GO7XG?\ !:__ ()IM_P4
M _9^@O? *6\/QV^$3ZEKWP[>41Q1:_!>QVHUGPC=7'ELX.I06<;:8S$)#J(C
M#,D4TKK^V5-<%E('7CKTX(//Y5VY9F&*RG'4,PP=1TZ^'J1G!]&D_>A+76$U
M>,EV9R8W!8?,,+6PF)AS4JT)1?>$FK1J1_OP=I1?>*OH?Y&?@[QG^T#^Q/\
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MO]I#X\:1JG@;]G/PY'^S]X3OUN;&?Q7#?#4OB'?6$C?));7BN;+0+@1_*SV
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M=33$XS#8.E[7%XBE0II?%5J1C]T6^9^B39^B>_!P&'!P.G.*4.3_ !?D ?\
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M9(X?=C*$J4TY4W&4:M/W9*2LVE)/1IK6UGYM/7_09_X(\_\ !<C1?VS[NP^
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M]><GO^!K_(!\;.P\6>)44>7_ ,5'KN&Z8QJEWZ'N./H17^O_ /$;_D1?&/\
MV*VO_P#IMGK_ " /'/\ R-OB7_L8M>_].EU7T/@XG&CQ%*,I1;^H)VLM'4FM
M';F3MU33ZIH\WCR*]KE<OM1AB[/L_P!P[VVNFNJ[G+9F_P">Y_[Z/^-.VW'_
M #V/_?7_ ->HJ][^!/[+GQ]_:5U#7=+^ OPJ\:?%?4?#-G:ZAK]IX0TV34I-
M*L[V:2WM;B\ D01I-/$R1G&2PZ5^RN?LXRJ5:SA1A9U*M3%JA"FKI)MU&T[V
MZ6M:W6-O@Z:Q-62C3O4U2Y5*$9MRLHJ$73FYMV=[+3K>^OA.+C_GN?\ OO\
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MYHUTEW:7,$J*61F0@Q7$+%HI[>4)-#*CQR(K*P'>[BS@G'#H..!P3[GU]:_
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M^Q*\9?\ IWMZ_D/;J?J?YU^@\!_\D;D'_8/BO_5ABSY/B7_DI,W_ .ON&_\
M5?@B1.A^O]!7^G)_P0U_Y1?_ ++W_8O>(O\ U+]7K_,;3H?K_05_IR?\$-?^
M47_[+W_8O>(O_4OU>OG_ !9_Y)S!?]C3#?\ IJL>KP-_R/*W_8OQ'_IS#GZZ
MKT/^\_\ Z&U.IJ]#_O/_ .AM3J_G*.R]%^1^M#)03&X'4J<?E]#_ "-?Q^?\
M'6W@*RF\#?LP?$N-$34+'Q3XR\(W,B0KYT]CJ5C9:G CR@#(AETV;"%@,S%E
M!.[;_8'*<1R$=0CD?@I-?R6?\'6'B>*S^!?[-?A0O!]HUKXD>)-76)@IN3%H
M^A&)WBXW",MJ*QM@JI9TZD+7W'AS.4.,,IY6USK&0G9VO!X2KH^]WHO.UM3Y
MWBM7R''/E3E!X9PNKVE+$TH2?RBWMMN?PZ_YYZ_C2@A<,>025&/7 ZY[8:FC
MH,YZ=^OX^].(+*@4$GS"< 9.,+S@<XK^HHI/E3Z<MEYW2MTOHWI;Y'XRHQ?+
M!W4;Q6CLTDUU/]%G_@VO\47WB/\ X)P:#9WLK2#PM\2_'OAVT#,6"6EO>VU]
M"JYY  U'&,+\P; VX+?T#5_.W_P;+:5>:=_P3L:ZN1MAUCXQ>/\ 4++L6@5]
M-LG.#V\ZT<@C (S[U_1)7\G<:PA3XKSV$/@CCYJ.M]Z=-O7_ !-G[=PXV\CR
MUN_^[)*Z:]V,YQCO_=2UZK7R*[???_=?_P!%K7^;?_P<3?\ *4/XM?\ 8H_#
MG_U&X*_TD&^^_P#NO_Z+6O\ -O\ ^#B;_E*'\6O^Q1^'/_J-P5]3X2_\E%CO
M^Q15_P#4O"GB\=?\BS#?]AT/_469^'*?>'X_R->T_LWG'QV^# ]?BUX YP#G
M_BKM)X*L"".>A]3Q7BR?>'X_R->T?LX?\EW^"_\ V5KP#_ZEVD5_0U3_ '?%
M_P#8%C?_ $R?FF$5ZOSH_P#IY'^O9#$##$<*,QH<8;C*CCAP/R 'L*5[:-U8
M,L;!EP048YQR.LA''N#SCTY? ?W,(Y_U4?8_W!WQBGDK\PW#.WID9QSSCKWK
M^*9;MWLT[I]4[Z->?8_?E\*TO=)-/9K2Z?D?G=^W3_P3>_9S_;C^&'B;PKX_
M\"Z%:>.KG3+H>$?B5IFFV-EXM\/:Q'#</IDBZQ':O>7&G)=R@W=C.\D,T1;(
M#JCK_E]_%7X?:I\*OB1X_P#AAXAECFUOX>^+_$/A'4YHB?)FOM U2YTZ:> L
M%)BGDMS+"2H!1E(P"#7^O;XF\0:'X1T'6?$_B'4;72M"T'3+W5M7U*ZF%O;V
M6G6-N]S=7,TS%42*&%&=F9MN!@GYJ_R7?VNO'>C_ !6_:@_:!^(V@R12:'XN
M^+'C?6='F0[DN=-GUR\%C=)TVBZMTCN-HRJ>9M!(7-?NGA!C<SKK.,+4J5:^
M"HT\/*E"NY.%.<W/GC"3;BDE&+Y%9)NZ2NS\XXWP^%PZPU:A3HT<16]HJWLD
MHN<8N'+*4>5-O6W/97M9MV1\V5^^/_!O7^UQXA_9[_;B\*_"Z[U:9/AI^T'#
M+X.\0:5/<3C3H?$D4$UWX:UB"W$H@34#<QOIAE:,F2&[VL?E7'X'5]<?L&7&
MIP_MF_LLRZ4\BWR?'GX9I 8V(8(_BO3XYU!'.TVYF#C'W2V>IS^GYW@\/C\F
MS3"8F+E3J8*O+2VCI1]HFKM*Z<4X]I6=U8^+R^O5PN/P=>C)1G3Q-+5NRM.:
MA)/39QE)/5:7^7^K;\0&W>!/&6 !CPKKO ]#I<S>WKC\/PK_ "!O'/\ R-OB
M7_L8M>_].EU7^OMX]7;X"\8XP ?"FN\>A&FW/';@*5QVQC%?Y!/CG_D;?$O_
M &,6O?\ ITNJ_+O!W_=^(?7+_N]I.W?H?;\=_'EG_7O%W];4;_>[G)U_7/\
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M#'K&EW,;3SVVE:Q/'"]QJ?A^6YDD-S9R,[QBXDE@(<8;]4*B=69B-N5V</D
MALG(QUZ 'T_6NS 8_&97BJ.-P%>6'Q.'DI4YQ=KVLG&47[M2+25XS4HNVJ;U
M.;%X3#XVA/#8F"J4:JY9)J[5^J>\6GJI1:<>C/\ )2_:_P#V-OCA^Q3\7-5^
M$GQO\+W.C:S:F2?0];@CEE\.>+=&W 0ZQX=U-TCCO;63*"6/"SVDQ:&XBC<8
M/RH%*L _ R.1SR>W^<Y_6O\ 6#_;9_80^!'[=GPIO?AM\:/"UK?74<5R_A'Q
MA:1K#XG\%ZS-;M%#JNCZA&\4IC6;9)=6$LAM+R,%;B%RJ%?\X[_@H3_P3<^/
MG_!/KXG7?A7XC:)=:K\/]2U.Y3X?_%&PM)&\-^*]/65WM4FG5GATO6UM5#W6
MDW,B3HZO)"DENR2M_27!O&V"XDHQH8B4<+G-."E4PTI1C'%M<JE4PW,[U).W
M-.G!7I];P]Y_D/$'#V(R6?M8-UL!.?+"NE?V+;3C'$-1Y::?,HPEM-Z)1DTC
MYQ_9*_Y.@_9__P"RT_#;_P!2O2Z_UQ-)_P"0/I?_ %X6?_I,E?Y'G[)0/_#4
M'[/_ $_Y+3\-LX(./^*KTOK@\$]L]?RK_7$T@$Z/I>/^?"S]O^7=/7%?%^,+
M7M,A5U?ES)VOK9U<-9VWL^CV9])P%_S-?)X*_E[E<_BD_P"#KO\ Y*3^RA_V
M)7C+_P!.]O7\A[=3]3_.OZ\?^#KP$?$K]E 'K_PA/C(_A_;%N.M?R'E222!P
M3D<CH:_0N ]>#L@2U_V?%;?]C'%K\]#Y3B5/_63-M-ZN&2\V\!@E;UOT&U^I
M?P'_ ."QG[>/[-7PJ\,?!GX2?%'3] ^'_@Z*\@T#2[GP[::A/9P7UY+?3Q?:
MYI5=T^TSRN@* KN(![U^6VQO3]1_C2[7/7)_'_Z]?38G X7'4U1QN#HXNG&I
M"K"&(H0JQC4A?EDE.+L_>UMI*Z33TMY=&MBL--U,-5K8><H2IRG2E*$G"?+S
M1NNCLGY.UMS]F[W_ (+[_P#!3B^M)[-OCG:6RW  :>S\+Z?;W,0QM_<3!V,1
M(QD@')YZ<5\0_&/]OS]LCX^VEUIOQ9_:*^*GB[1KR3S+C0KSQ;JL&B-@DA5T
MRSGM[94&=NPJRE>""*^0=C>GZC_&FME<9!Y.!@%O_00<?CBN2CD^4823J8?*
M\OP\N;G<X82A&2EIKS.%UTT32UVU'4Q>,JJ4:^-Q=9/>-7$59QT:?P2FXJS2
M>VFA+),TA+'AF)9F)+,Y8DN7)/S,22=QY!YY.28J55+D #&3@;OD&?0EL8_&
MOH_]F_\ 9*_:"_:Q\<V7P]^!/PT\0^.=<NY84NKBQM)(]$T:&:0(M[K>N2QC
M3=*LXVRTDUW<Q JC!0QX/=6KTJ5.6(Q%:G1H0LIUJLX4J%-67Q3DXTJ:M9N[
M2MJ^YE3A4KU%"C"=:K/X:=*+J5)6M=0IP3E*RVC%:M]V>#:+H6L>(M5T[0M"
MTV^U?6]7NH+'2],TZVEN[R^NKMUCM[>WMX09999F<*B("23C& :_T3O^"%W_
M  2Y7]B3X+M\6?BKI$4/[1/Q<T^"YUV"Z@@DN? 7A246]UI_@^UG&YHKQY$C
MO=:>)RKW)6U!=(,MS?\ P2I_X(2?#7]BZ;0_C1\<9=/^*/[1,,$5YIC*C/X0
M^'-Q-!(CP:!:RRJ-2U:%)F236;V!6BE4M8+ O)_H:B3:A4IM . IP1M  !P"
M0 <9"CH.H!S7X-Q_QY3S)3R7))N67MI8S&:7Q,H.ZIT6KIT7))RJ0Y>=:)NF
MWS?IG"_#3PKAF6.@X8CE?U?#S34Z*G%*4JL=.6;Z0DGR=5S[/"X(.<G&/Y=/
M0<=.:=117Y'L?==_/4K287S6.,D$K^$?0\C/(]1]:_DY_P""H_\ P0D_:*_;
M=_;!\:?M"_#OXB?#SP_X:\3^'?".FV^E^(AJPU."?0M+^P7+2_9+66';)(F^
M/#D[6 .,9;^L^BO8R'/LPX<QL\;ELJ:K5*%2A/VL/:1=.=2%2UN:+34EIK:V
MEK'!F6787-,/]6Q49.GS1DG"7+.,HVUC*SLVE9^39_!%_P 0MW[8G_17_A!_
MY7__ )!H_P"(6[]L3_HK_P (/_*__P#(-?WNT5]A_P 14XK_ .?N#_\ "9^7
M_3SR_%]SP/\ 4K)?^HO_ ,*'Y?W?)_?Y'\$7_$+=^V)_T5_X0?\ E?\ _D&F
MG_@UK_;#)R?C#\'Q]3KN?R-F/Z?UK^]^BD_%/BMK^+@UJG_NSZ6_Z>>7XON)
M\$9))6:Q;7_80_+^X_-_/R/X9_"/_!JG\>;R4'QA^TG\.- A,8+_ -F^&=;U
MJ7>2/D17N-.C8GYB"9!C;C!+ C]!O@A_P:[?LI^$9--U'XT?%?XD?%'4K.>&
M>ZTS1[G2O"?AJ]97S+!<6BZ=?:J8'0+&%CU.*107W/)D5_4E17!B_$7B[%Q=
M-YI+#P?V<+2ITK=[2Y93U_Q:=+'5A>$LCPKYHX>K5>NE;$5)Q=[;PTATZ15^
MMSYY^ 7[+GP!_9@\)6W@OX%_##PE\/-%M8E1TT/2;2WOKUMH5KC4]3\HZAJ=
MQ)@&26]N)F)R> :^A$^XO(/RCD8QT]N/RIU%?&5Z];%5I8C$UJU>M/XZE:I*
MI*6V[E=WT[_(^AI4:="G&E1ITZ5*/PPA!12V[:6^7Y'->+M*GUOPYKVD6S)'
M/JFBZEIT,D@)1);RUDAC=@""55V5F /*@@8)!'\+FO?\&OG[7FI:]K>HVWQ<
M^$B6^I:OJ5_;K.==$HANKR:>,.JVC .$=0X4L 0?F."U?WD45[_#_%6;<-?6
M5EDZ,?K4H2J^UI>T7[M627O1MI>[\]-CRLUR+ YS.A/&*M?#PE"'LJCIZ2<6
M^:R=_A6_7K;0_@B_XA;OVQ/^BO\ P@_\K_\ \@T?\0MW[8G_ $5_X0?^5_\
M^0:_O=HKZ3_B*G%?_/W!_P#A,_+_ *>>7XON>5_J5DO_ %%_^%#\O[OD_O\
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AVC%:U).4[:+3FWU$ P ,YP ,^N!UI:**\8]$**** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
